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ABSTRACT
In Exp. 1 ,42 calves were fed milk replacer and then starter either with or without
1 ppm supplemental chromium (Cr) as Cr-picolinate. Neither Cr nor sex affected growth
performance. With the exception o f plasma nonesterified fatty acid concentrations (NEFA),
weekly plasma metabolites were not affected by Cr or sex. Pre- and postfeeding plasma
NEFA concentrations were lower in Cr-fed calves, but were not affected by sex. All calves
seemed to become less insulin sensitive with age, as plasma glucose became lower and
insulin higher as calves became older. During i.v. glucose tolerance tests (IVGTT), calves
cleared glucose fester at 2 compared with 8 weeks o f age but Cr did not affect clearance at
either week. At 2 weeks o f age, heifers cleared glucose faster than did bulls. Plasma
glucose increases after an i.v. propionate load were greater in heifers than in bulls but were
not affected by Cr.
In Exp. 2 ,3 4 calves were fed milk replacers either without (BF) or with (HF) added
fat and either with or without 1 ppm o f dietary Cr as Cr-nicotinate. Neither Cr nor fet
affected performance; except, weight gain was greater in HF-fed calves during the period
calves received milk alone.

Weekly plasma glucose, insulin, and triacylglycerol

concentrations were not affected by Cr; however, plasma insulin concentrations tended to
be lower in Cr-fed compared with control-fed calves. Weekly NEFA declined in a similar
manner for Cr-fed and control-fed calves; however, overall, NEFA concentrations were
greater in Cr-fed calves. Weekly cholesterol concentrations were greater in Cr, HF-fed
calves and lower in Cr, BF-fed calves compared with controls. Added dietary Cr or fat had
minimal effects on plasma metabolites and hormones measured after milk replacer feeding.
xi
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Using data generated by the IVGTT, a computer modeling procedure predicted that insulin
sensitivity was increased in Cr-fed calves but reduced in HF-fed calves compared with
controls.

Overall, data suggested that Cr had little effect on metabolism or growth

performance, but may have improved insulin sensitivity, with the most notable effects
occurring in the initial weeks o f life.

xii
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CHAPTER I
INTRODUCTION
The essentiality o f dietary Cr for man and many laboratory species has been
reasonably well established (Anderson, 1987; Mertz, 1993). The most convincing evidence
comes from long-term total parenteral nutrition studies in humans (Jeejeebhoy et al., 1977;
Freund et al., 1979; Brown et al., 1986) and from feeding low-Cr diets to laboratory animals
(Schroeder et al., 1963a,b; Mertz et a l, 1965a,b; Hopkins, 1965; Onkelinx, 1977; Kraszeski
et al., 1979; Jain et al., 1981). These studies demonstrated that a Cr deficiency impairs
glucose tolerance and that supplementation o f physiological amounts o f Cr reestablished
normal glucose tolerance.
The only established metabolic role o f Cr is its function in the glucose tolerance
factor (GTF), where Cr is believed to play a physiological role as a co-factor for facilitating
insulin’s attachment to its receptors (Mertz, 1979; Offenbacher and Pi-Sunyer, 1988; Mertz,
1993). In monogastric species, insulin has a multiplicity of effects within the body: it acts
on a variety o f tissues including muscle, adipose, liver, and mammary, and alters a variety
o f processes including membrane translocases, enzyme activity, and enzyme amounts
(Vemon and Sasaki, 1991). M ore specifically, insulin enhances glucose uptake by adipose
and muscle cells, enhances amino acid uptake by muscle cells, stimulates protein synthesis,
and inhibits protein degradation; thus, in general, insulin promotes tissue growth (Granner,
1996). In ruminants, insulin has many similar effects, but these effects, especially on adipose
and muscle tissue, are generally less pronounced than those observed in monogastric
animals. The smaller response to insulin o f ruminants tissues have been attributed to the

1
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pattern of feeding and the action o f the rumen, both o f which minimize the surge o f
nutrients, especially glucose, into the blood stream. Because the influx o f nutrients into the
blood following a meal is less episodic in ruminants, there appears to be less need for tissues
to be as acutely sensitive to insulin. In other words, the need for insulin to act rapidly to
move nutrients into storage (i.e., glucose and amino adds into muscle and glucose and lipids
into fat) is not as much of a priority. Nevertheless, insulin in ruminants increases on feeding
(Bassett, 1975), and development o f diabetic-like conditions can be as severe in ruminants
as in monogastrics (Jarrett et al., 1974). Because Cr is a component o f the GTF-complex,
because the GTF is important for optimum insulin effectiveness, and because insulin is
involved in regulating a multiplidty o f metabolic events, it seems plausible that any system
upon which insulin has an influence would work most efficiently when an animal’s Cr
requirement is satisfied.
As alluded to above, ruminants derive small amounts o f glucose from intestinal
absorption and the role o f insulin in these animals is perhaps less well defined than in the
nonruminant animal (Brockman, 1986). By contrast, the pre-weaned calf continues to
absorb glucose primarily through the small intestine until its rumen begins to function as a
result o f consuming dry feed (Quigley et al., 1991). Therefore, until such time, the calf s
absorption o f nutrients is more like that o f a monogastric than that o f an adult ruminant.
Evidence has shown that tissue sensitivity to insulin is greater in the preruminant compared
with the adult ruminant animal, but less than that o f the monogastric (Thiebaud et al., 1983;
Weekes et al., 1983; Farrell et al., 1988; M etcalf and Weekes, 1990; Grutter and Blum,
1991; Sano et al., 1991).

Furthermore, irrespective o f the feeding regime employed
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(intensively or conventionally-fed), insulin sensitivity will decrease with age. Development
o f the rumen as a result o f dry feed intake however will make the calf become more insulin
insensitive at an earlier age. Hostettler-Allen et al. (1994) showed that insulin and glucose
concentrations in intensively-fed calves eventually become elevated to the point that there
is the potential for urinary spillage o f blood glucose, delayed initiation o f gluconeogenic
processes, and reduced feed efficiency. Although such exaggerated changes in insulin and
blood glucose are less likely in conventionally-fed calves, it is possible that glycosuria,
delayed initiation o f gluconeogenic processes, and reduced feed efficiency might also exist
in these calves. Because newborn ruminants progressively become insulin insensitive with
age, it is conceivable that slowing the rate at which this occurs may translate into a
metabolically more efficient animal. Improving insulin’s effectiveness may also improve
immune modulation (i.e., enhance disease resistance) which in turn may result in greater and
(or) more efficient rates o f gain.
Our primary hypothesis is that insulin sensitivity declines with age in conventionally
raised dairy calves and that supplemental Cr can slow this decline. To test this hypothesis,
two experiments were conducted to evaluate physiological (metabolic and hormonal)
responses and performance criteria (gain, intake, efficiency) o f conventionally-fed dairy
calves to supplemental organic Cr. Our objectives were 1) to determine if supplemental Cr
would influence insulin sensitivity (i.e., effectiveness), as measured by changes in insulin and
glucose concentrations following milk feedings and following intravenous infusions o f
glucose, 2) to determine if supplemental Cr would influence gluconeogenesis, as measured
by an intravenous infusion o f propionate, 3) to determine if supplemental Cr would influence
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4
circulating blood lipids and lipolysis, as measured by changes in glucose and blood lipid
concentrations following milk feedings and following an intravenous infusion o f epinephrine,
and 4) to determine if supplemental Cr would influence growth performance (starter intake,
body weight gain, and feed efficiency).
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CHAPTER II
REVIEW OF LITERATURE
Historical Background o f Chromium
Dietary chromium (Cr) research began more than forty years ago. Until recently (5
to 10 years ago) the majority o f research has been conducted in hum ans and laboratory
animals, as opposed to livestock. The earliest work, conducted in rats, revealed that Cr was
required for maintaining normal glucose tolerance (Schwarz and Mertz, 1959). Since then,
this response has been shown in humans, mice, squirrels, monkeys, and guinea pigs
(Anderson, 1987).

According to Anderson (1987), hyperinsulinemia (human, rat),

glycosuria (human, rat), fasting hyperglycemia (human, rat, mouse), elevated serum
cholesterol and triglycerides (human, rat, mouse), impaired growth (rat, mouse, turkey), and
decreased longevity (rat, mouse) are among some o f the symptoms that have been attributed
to a deficiency in Cr. In humans, the dietary need for a source o f Cr that can be used by the
body to form the GTF-complex has been firmly established. The most convincing evidence
for a Cr deficiency to lead to negative consequences (i.e., impaired glucose tolerance,
requirement for exogenous insulin, peripheral neuropathy, decrease in body weight) has
been observed in patients on long-term total parenteral nutrition (Jeejeebhoy et al., 1977;
Freund et al., 1979; Brown et al., 1986). For example, Jeejeebhoy (1977) and co-workers
showed that addition o f 250 /j.g/d o f Cr (as CrCl3) into infusion solutions for two wk
returned glucose tolerance to normal, peripheral neuropathy disappeared, body weight (BW)
returned to normal, and exogenous insulin was no longer needed.

5
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Currently, the only established Cr recommendation set forth by the National
Research Council (NRC) has been for lactating, gestating, or growing laboratory rats (0.3
ppm; NRC, 1995). Based on estimates o f the Cr content of typical diets the NRC suggests
a safe and adequate level o f 2 ppm for the mouse, and an allowance o f 0.6 ppm for the
guinea pig (NRC, 1995). In adult humans, an intake o f 50to 200 //g/d is recommended as
a safe and adequate level (NRC, 1989a). For poultry, the NRC does not suggest a Cr
requirement (NRC, 1994) however, based on available data it has been suggested that Cr
will eventually be recommended at 3 ppm (Puls, 1990).
Among commercial livestock, the FDA only allows supplemental Cr to be added to
swine diets. In contrast, Cr supplementation to livestock diets, in most foreign countries,
is allowed. The NRC currently does not provide any recommended Cr level for livestock
diets but does recognize that some source o f Cr that can be incorporated in the GTF is
needed (NRC, 1988a,b; NRC, 1989a,b; NRC, 1994; NRC, 1995; NRC, 1996). As data
continue to emerge regarding Cr essentiality in livestock diets, there will be increasing
pressure to approve the use of Cr in mineral supplements. Recently, the NRC (1997)
published a book entitled The Role o f Chromium in Animal Nutrition that covers the
majority o f Cr research that has been conducted in livestock animals. Although some data
supports improved performance, many o f the proposed benefits are less obvious, such as
improved immune response, enhanced reproduction, improved recovery from stress and (or)
resistance to disease, and decreased incidences o f metabolic disorders.

Because

supplemental Cr appears to act more as a nutrient than as a pharmacological agent, it is
believed that any beneficial effects may be limited to situations where an animal is clearly or
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at least marginally deficient in Cr (Anderson, 1986). Progress toward establishing Cr
requirements for livestock has been slow and undoubtedly will continue to be slow until
simple, inexpensive methods become available to evaluate the bioavailability (i.e., absorption
and retention) and biological activity (i.e., ability to potentiate insulin) o f Cr in feeds and
supplements. Although a variety o f Cr supplements (Cr-nicotinate, CrCl3 Cr-picolinate,
chelated Cr, and high-Cr-yeast, among others) have been included in livestock diets,
relatively few comparative studies, especially in ruminants, have been conducted. The lack
o f comparative studies also appears to be a factor that has hindered the progress toward
establishing Cr requirements for livestock.
Biologically Active Forms o f Chromium
Chromium exists in oxidation states varying from -2 to +6 (Mertz, 1969).
However, its most stable state and the state most likely to persist and have metabolic activity
in biological systems, is the trivalent or +3 state (Mertz, 1969; Borel and Anderson, 1984;
Wallach, 1985; Kumpulainen, 1988; Ducros, 1992). As previously mentioned, it is the
GTF-complex, o f which trivalent Cr is an active component, that possesses biological
activity. The exact structure o f the GTF is not known; however, it appears to be composed
o f Cr, nicotinic acid, and the amino acids glycine, cysteine, and glutamic acid (Mertz et al.,
1978; Toepfer et al., 1977). The mechanism(s) by which biologically active Cr improves
glucose tolerance and (or) insulin effectiveness is not fully understood. However, proposed
theories include more efficient binding o f insulin to its receptors (Mertz and Roginski, 1963;
Mertz, 1969; Anderson, 1987), increased production or membrane insertion rates o f insulin
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receptors (Anderson, 1986; Evans and Bowman, 1992), or possibly, a combination o f the
two mechanisms (Anderson, 1987).
Similar mechanistic alterations have been used to explain the onset o f reduced insulin
sensitivity in humans consuming diets high in fat (Kolterman et al., 1980; Marangou et al.,
1986; Bonadonna et al., 1990). Because insulin insensitivity, at least in humans and some
laboratory animals, can develop rapidly in response to the level o f dietary fat consumed (i.e.,
within d depending on the percentage o f energy in the diet coming from fat), it has been
suggested that the change (i.e., reduced insulin sensitivity) may primarily be a response to
fat intake, and that obesity only exaggerates the effect (Harris and Kor, 1992). This further
suggests that tissue sensitivity to insulin is in all likelihood maintained/regulated by both
acute (i.e., binding capacity o f insulin receptors) and longer term (post-receptor)
mechanistic changes at the cellular level.
Supplementation o f both organic and inorganic trivalent Cr have been shown to elicit
biological responses; although, the degree to which, and the time required before,
observable biological responses are elicited, seem to vary. An understanding o f why these
differences occur is not readily apparent, but it is known that bioavailability (i.e., absorption
and retention) and biological activity (i.e., ability to potentiate insulin) varies among the Cr
compounds that have been included in diets to increase Cr intake. In processed feeds and
foods the Cr that exists is not well understood; however, it is thought that most o f this Cr
is in a form that provides little, if any, Cr to the glucose tolerance factor complex. Inorganic
sources o f Cr are also thought to provide little, if any, benefit as a source o f Cr for the GTF
complex (Mertz et al., 1965; Anderson et al., 1983; Anderson and Kozlovsky, 1985;
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Anderson, 1988) until converted to an organic form, but where or how this may occur is
unclear (Borel and Anderson, 1984).
The absorption o f inorganic Cr has been estimated to be between 0.4% and 3%
(Dowling et al., 1989), similar to that which has been reported for Cr found inherently in
feed (0.5 and 2.0%; Anderson and Kozlovsky, 1985). Organic synthetic Cr is thought to
be absorbed three to fourfold more effectively than inorganic Cr (Evans, 1989b; Mertz,
1976), but may still be less than the 10 to 25% estimated absorption from the organic form
found in Brewer’s yeast (Mertz, 1976).

More recently, humans given 400 fig Cr as Cr

picolinate/d were estimated to have absorbed only 2.5% o f the Cr (Gargas et al., 1994).
Current thinking is that only organic trivalent Cr will be incorporated into the GTF complex.
In addition to the previously mentioned factors that have hindered estimating Cr
requirements, Cr analysis is technically demanding and requires specialized instruments
capable o f making sophisticated background corrections. Furthermore, questions persist
as to whether the total Cr content o f a diet bears much, if any, relationship to its biological
activity (Vobecky et al., 1979).
Effect o f Chromium on Carbohydrate Metabolism
Impaired glucose tolerance (i.e., when glucose is cleared from the blood at a slower
rate) is the classical metabolic observation resulting from a Cr deficiency (Wallach, 1985;
Mertz, 1993). Although the mechanistic effect(s) o f Cr, or more accurately the Cr-GTFcomplex, at the cellular level (i.e., receptor) still need to be clarified, it appears that impaired
(i.e., decreased) insulin responsiveness (i.e., effectiveness) may be the fundamental
biological malfunction, and that all other symptoms that manifest themselves are a
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consequence of this malfunction. In support o f this, studies with epididymal fat tissue taken
from Cr-sufficient and Cr-deficient rats showed that exogenous insulin only increased
glucose uptake in tissues taken from Cr-sufficient rats (Mertz, et al., 1961; Mertz and
Roginski, 1971; Mertz, 1981). Tissue samples from the Cr-sufficient rats were also able to
convert more glucose to glycogen (Roginski and Mertz, 1969). In vitro, the addition of
glucose and insulin failed to increase 51Cr binding to tissues (brain, kidney, liver) in which
glucose uptake is independent o f insulin, but in insulin sensitive tissues (muscle, adipose)
glucose and insulin increased 51Cr binding (Morris et al., 1993). In hypoglycemic patients
receiving supplemental Cr, insulin binding and insulin receptor numbers on red blood cells
were observed to have increased (Anderson et al., 1987). Likewise, Berrio et al. (1995)
showed that red blood cell ghosts and isolated adipocytes obtained from pigs fed diets
containing Cr had a greater ability to bind insulin.
In humans and laboratory animals, ingestion o f high (> 40% of energy) and moderate
(> 30% o f energy) fat diets has been shown to reduce insulin sensitivity within d or wk,
respectively (Storlein et al., 1986; Sidery et al., 1990). Studies of this nature (i.e., added
fat) have been interpreted to suggest that both immediate (i.e., binding to receptors) and
longer term (i.e., post-receptor) mechanistic alterations are probably involved in regulating
insulin sensitivity (Harris and Kor, 1992). Supplementation o f Cr (as CrCI3) to humans
considered to be hyperglycemic and hypoglycemic resulted in lower and greater glucose
concentrations, respectively, at 90 min following a glucose challenge (Anderson et al.,
1983). These findings suggest that Cr is probably involved in more than just increasing
insulin’s binding capacity to its receptors and that post-receptor changes are also occurring.
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Further evidence that the mechanistic effects o f C r (i.e., GTF) are mediated through insulin
action is strengthened by the observation that supplementing Cr, in the absence o f insulin,
did not increase glucose uptake by insulin sensitive tissues (Anderson, 1987).
Human and Laboratory Animal Studies. In overt-diabetic individuals displaying
abnormal glucose tolerance following an oral glucose tolerance test, supplemental Cr was
found to increase glucose clearance (Liu and Morris, 1978; Grant and McMullen, 1982;
Polansky et al., 1982). Similarly, Elias et al. (1984) showed that giving supplemental Cr to
Type-II diabetics increased insulin sensitivity in these subjects and reduced their dependence
for exogenous insulin. Mildly-hyperglycemic individuals consuming diets low in Cr were
observed to display low glucose tolerance; however, once subjects began receiving
supplemental Cr, glucose tolerance returned to normal (Anderson et al., 1991). In this study
circulating insulin concentrations also returned toward more physiological normal levels.
In elderly volunteers fed a Cr-rich Brewer’s yeast as opposed to a Cr-deficient Torula yeast
Offenbacher and Pi-Sunyer (1980) observed that the volunteers fed the Cr-rich yeast had
greater glucose tolerance and lower plasma insulin levels. Administration o f supplemental
Cr orally, intravenously, and via a stomach tube to rats has also been shown to lower fasting
glucose concentrations and increase glucose clearance (Mertz, 1974b; Mertz, 1976; Evans,
1989a; Evans, 1991; Evans and Pouchnik, 1993). Although both, organic and inorganic
forms o f Cr have been shown to decrease fasting serum glucose concentrations, Vinson and
Hsiao (1985) reported greater decrease’s following supplementation o f organic Cr.
Livestock Studies. After an early study showed that a synthetic, Cr-containing GTF
substance was biologically active in pigs (Steele et al., 1977) there was a lag o f 10 to 13
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years before studies were again initiated. Since then a plethora of studies have been
conducted to evaluate different Cr compounds and to establish Cr requirements. The
majority o f studies however have been designed to investigate whether growth performance
or carcass criteria were affected, and not necessarily whether glucose homeostasis or insulin
action were influenced. Nonetheless, some studies have provided evidence to suggest that
supplementing diets with Cr may improve insulin action in pigs (Evock-Clover et al., 1993;
Lindemann et al., 1995; Amoikon et al., 1995). Berrio et al. (1995) also showed that
binding o f insulin to red blood ghosts cells and isolated adipocytes was greater in samples
taken from Cr-fed compared with control-fed pigs. By contrast, Ward et al. (1994) found
less binding o f insulin to liver cell membranes in samples taken from Cr-fed compared with
control-fed pigs.
Ruminants use volatile fatty acids rather than glucose as their major energy source
and their response to insulin is perhaps less well defined than that of monogastric animals.
Insulin seems to have less anabolic effect on ruminant muscle and adipose tissues (Vernon
and Sasaki, 1991; Lobley, 1993) and glucose uptake by the mammary cells appears to be
independent o f the action o f insulin (Brockman, 1986; Vernon and Sasaki, 1991).
Superficially, there seems little reason to anticipate that supplemental Cr would be o f benefit
to the ruminant. Nonetheless, impaired insulin effectiveness (i.e., non-insulin diabetic-like
state) can be as severe in ruminants as in nonruminant species (Jarrett et al., 1974; Vernon
and Sasaki, 1991). Insulin resistance induced in lactating cows by feeding o f supplemental
fat has also beat shown to impair amino acid transport into the mammary gland (Palmquist
and M oser, 1981). Although insulin has similar metabolic effects in nonruminant and
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ruminant animals, its effects on insulin-dependent tissues in ruminants are generally less
apparent (Vernon and Sasaki, 1991). It seems plausible that supplementing Cr in the diets
fed to ruminants should produce metabolic changes similar to those that have been observed
in nonruminants.
In ruminants, the majority o f Cr-supplementation studies have been conducted with
“market-transit” stressed feeder calves (Chang and Mowat, 1992; Mowat et al., 1993;
Chang et al., 1995; Kegley and Spears, 1995; Kegley et al., 1997b). In these studies, Cr
sources (high-Cr yeast, CrCl3, chelated Cr), supplementation levels (ranged from 0.4 to 1
ppm), and the d on which blood variables were measured differed from study to study.
Therefore, some confounding factors may exist in summarizing these studies together.
Nonetheless these studies all began Cr supplementation following the calves’ arrival at the
experimental site (i.e., after transit) and, overall, found a slight tendency (not always
significant) for Cr-fed calves to have lower prefeeding glucose concentrations during the
first month after arrival; however, over time, this effect gradually diminished. In the study
conducted by Kegley and Spears (1995) postfeeding (2 h) glucose concentrations were not
affected by supplemental Cr (as CrCl3, high-Cr yeast, or Cr nicotinic acid complex).
However, during an IVGTT (wk 9 o f Cr supplementation) the steers receiving the Cr
nicotinic acid complex tended to clear glucose faster than steers receiving the other Cr
sources, but clearance rates between any one o f the individual groups o f Cr-fed steers did
not differ from the group o f control-fed steers.
When Cr, as Cr picolinate, was supplemented for 8 wk, in a com-cottonseed hull
basal diet fed to Holstein calves (steers and heifers) considered physiologically adapted, no
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differences in prefeeding glucose or insulin concentrations were observed between the Crfed and the control-fed calves (Bunting et al., 1994). However, during an IVGTT the Crfed steers and heifers cleared glucose fester (40 and 27%, respectively). In addition, during
an IVICT, the Cr-fed heifers cleared glucose fester (44% fester than control-fed heifers) and
the Cr-fed steers tended to clear glucose faster (27% faster than control-fed bulls). The
faster glucose clearance rates were interpreted to suggest that Cr had increased the
sensitivity o f these calves’ tissues to insulin. In weaned lambs, prefeeding glucose and
insulin concentrations were also not affected when supplemental Cr picolinate was fed
(Fom ea et al., 1994; Kitchalong et al., 1995; DePew et al., 1996; Forbes et al., 1998).
Kitchaiong et al. (1995) and Forbes et al. (1998) also did not observe any differences when
the glucose clearance rates obtained from the IVGTT and IVICT were compared between
Cr-fed and control-fed lambs. However, Kitchalong et al. (1995) did observe that Cr-fed
lambs had lower glucose and greater insulin concentrations in response to the IVICT
conducted 2 wk after supplementation was begun compared with what was observed after
10 vie o f Cr supplementation. In growing lambs, Samsell and Spears (1989) reported that
prefeeding plasma glucose and insulin concentrations were also not affected by supplemental
Cr, as CrCl3 However, they did note that Cr supplementation lowered fasting (48 h) plasma
glucose concentrations in lambs fed the low-fiber diet.
Kegley and Spears (1997a) conducted an experiment to determine if Cr
supplementation would affect glucose metabolism and (or) insulin effectiveness in milk-fed
Holstein bull calves. Calves were obtained from a local dairy at approximately 1 wk o f age
and fed a commercial milk replacer without or with supplemental Cr (.4 ppm) as either CrCl3
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or a Cr nicotinic acid complex throughout the next 9 to 10 wk of life.

Glucose

concentrations before and after feeding (1 h) were not different between Cr-fed and controlfed calves on any o f the individual sampling d. Because glucose concentrations increased
with age the authors speculated that the rise was a reflection o f increased dietary lactose
intakes as milk intake was adjusted to weight gain, or was a reflection o f increased insulin
resistance.
Effect o f Chromium on Lipid Metabolism
Perhaps the most consistently observed metabolic effects to supplemental Cr have
been changes in blood lipid concentrations. Most notably, supplemental Cr has been
reported to lower circulating cholesterol and NEFA concentrations in humans and
Iaboratoiy animals (Doisy et al., 1976; Liu and Morris, 1978; Anderson et al., 1988; Mertz,
1993), pigs (Page et al., 1993), as well as in ruminants (Samsell and Spears, 1989; Bunting
et al., 1994; Kitchalong et al., 1995; Yang et al., 1996).
Human and Laboratory Animal Studies. In middle-aged men, Wang et al. (1989)
reported that individuals fed the CrCl3 or Cr-rich Brewer’s yeast had lower total cholesterol
and low density lipoprotein cholesterol concentrations compared with individual fed a
placebo. Similarly, Offenbacher and Pi-Sunyer (1980) reported that elderly-individuals fed
a Cr-rich Brewer’s yeast had lower plasma cholesterol and total lipids when compared with
individuals fed a Cr-deficient Torula yeast for 8 wk. Chromium supplementation has also
been reported to reduce total cholesterol, low density lipoprotein cholesterol, and
triacylglycerol concentrations, and increase high density lipoprotein concentrations in
humans considered to be mildly hypercholesteremic (Press et al., 1990; Abraham et al.,
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1992). In addition, Cr supplementation o f various Cr sources has been reported to result
in similar reductions in cholesterol levels in healthy individuals and weight-training athletes
(Press et al., 1990; Lefavi et al., 1993).

In rats fed hypercholesterolemic diets, Cr

supplementation has been reported to decrease total cholesterol concentrations (Staub et
al., 1969). O’Flaherty and McCarty (1978) also reported that Cr-fed rats released less
NEFA from adipose tissues compared with control-fed rats. In various laboratory animals,
decreases in total hepatic lipid content and decreased occurrences o f aortic plaques have
been observed following Cr supplementation to animals fed both typical and high-cholesterol
diets (Abraham et al., 1980; Abraham et al., 1982a,b; Schroeder and Balassa, 1985; Li and
Stoecker, 1986).
Livestock Studies. Page et al. (1993) reported that total cholesterol concentrations
were lower in pigs fed Cr picolinate than in control-fed pigs. By contrast, Evock-Clover et
al. (1993) and Amoikon et al. (1995) reported that total cholesterol concentrations were
greater in pigs fed Cr picolinate than in control-fed pigs. In addition, Evock-Clover et al.
(1993) also reported that high-density lipoprotein cholesterol concentrations were increased
in Cr-fed compared with control-fed pigs. Kitchalong et al. (1995) reported that lambs fed
Cr picolinate had lower cholesterol concentrations compared with control-fed lambs after
2 wk on the experimental diet; however, this effect was no longer apparent during the 7th
or 11th wk o f the trial. Forbes et al. (1998) also observed that supplemental Cr did not
affect cholesterol concentrations in lambs. Kegley et al. (1997a) reported that milk-fed
Holstein bulls receiving supplemental Cr, as CrCl3 or a Cr-nicotinic acid compound, had
similar postfeeding (3 h) cholesterol concentrations throughout the 9 to 10 wk study when
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compared with control-fed bulls. Holstein steers and heifers fed com-cottonseed hull based
diets supplemented with Cr-picolinate had lower total plasma cholesterol concentrations at
some individual sampling times (wk 4 and 6 for steers and calves, respectively) but overall
no difference was observed (Bunting et al., 1994). In Holstein steers and heifers, Bunting
et al. (1994) reported no effect o f supplemental Cr picolinate on NEFA concentrations; by
contrast, in yearling ewes (Forbes et al., 1998) and weaned lambs (Kitchalong et al., 1995)
addition o f Cr picolinate to basal diets lowered NEFA concentrations. The mechanism o f
action o f Cr on lipid metabolism is not understood. However, Mertz (1993) suggested that
the more dramatic hypolipidemic effects o f organic Cr in humans may be attributable simply
to increased glucose tolerance with corresponding reductions in lipolysis. Samsell and
Spears (1989) hypothesized that the effects o f Cr on lipogenesis were probably being
influenced through the actions o f insulin.
Chromium and the Neonate
Information regarding Cr nutrition before weaning is basically limited to determining
the Cr content o f neonatal food sources (i.e., breast milk, infant formula, etc.) and
epidemiological comparisons o f Cr status among different population groups by measuring
Cr content in urine, tissue, and hair samples. From studies that have measured the Cr status
o f pre- and full-term infants and infants from diabetic and non-diabetic mothers, it has been
determined that the Cr content o f newborns is two and one-half times that o f their mothers.
The fetus concentrates Cr in-utero, and the Cr status of the newborn has a correlation to
that o f the mother’s Cr nutritional state (Hambidge and Baum, 1971; Saner and Gurson,
1976; Friel et al., 1985). It has also been observed that urinary Cr concentrations increase
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significantly by the 3rd d postnatally (Saner and Gurson, 1976; Saner, 1979) and that tissue
Cr levels decline in later infancy (Hambidge and Baum, 1971). Although the relative
importance o f dietary Cr throughout the postnatal period is uncertain (Friel et al., 1985), Cr
metabolism is evidently initiated early in life. The best support for this seems to come from
studies with malnourished infants, where it has been observed that Cr supplementation
improves glucose tolerance (Hopkins et al., 1968; Gurson and Saner, 1971).
The American Academy o f Pediatrics recommends that breast milk be the sole
source o f nutrients for infants until about 4-6 mo o f age (American Academy o f Pediatrics,
1976). Friel et al. (1985) reported that the major source o f Cr for infants comes from milk
sources; however, milk, particularly artificial milk formulas, reportedly contain low
concentrations o f Cr (Hambidge, 1974).

Other studies report that the Cr content o f

commercial milk formulas is greater than that o f human breast milk (Vobecky et al., 1979;
Kumpulainen and Vuori, 1980; Casey and Hambidge, 1984). Whichever the case, the Cr
obtained from milk sources is considered small. As with most Cr measurements, the
concentration o f Cr measured in human breast milk has decreased over the past thirty years;
ranging from a high o f 50.5 ng/mL in 1966 to a low o f 0.18 ng/mL in 1992 (Anderson et
al., 1993). Similarly, the Cr content o f cows’ milk is also considered small and probably
provides less than 0.5 ng/mL (Anderson et al., 1992). Improvements in methods o f analysis
and an increased awareness o f Cr contamination during all phases o f collection and analysis
have led to increasingly accurate values for Cr in tissues and body fluids over the past
decade. The older values for Cr, in hair, however, appear to still be reliable because hair
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contains 200- to 1000-fold higher levels o f Cr compared with those contained in tissue and
body fluid samples (Anderson et al., 1993).
Anderson et al. (1993) reported that by d 60 postpartum the Cr concentration o f
human breast milk was 0.18 ng/mL. At this concentration, when breast milk is the sole
source o f Cr intake, an infant would need to consume 55.6 L in order to obtain the minimum
suggested Cr intake o f 10 //g/d. Realistically, at a typical daily breast milk intake o f 715
mL/d by d 60 postpartum (Borschel et al., 1986) an infant would receive less than 2% o f the
minimum estimated safe and adequate daily intake for infants less than 6 months o f age
(Anderson et al., 1993).
An adequate dietary intake o f Cr appears to be of particular concern for pregnant
and lactadng females, because during these states there is an increased burden placed on Cr
stores (Hambidge and Baum, 1971; Mahalko and Bennion, 1976). By using hair Cr
concentrations as a reflection of Cr status, it has been determined that Cr concentrations are
greater in primiparous than multiparous women (Hambidge and Rodgerson, 1969; Mahalko
and Beenion, 1976). Mahalko and Bennion (1976) further observed that it takes more than
four years between pregnancies before hair Cr concentrations return to pre-pregnancy levels.
Thus it follows that an infant born within four years of its sibling would have a greater
likelihood o f being Cr deficient. Extrapolation o f these findings to newborn ruminants
would suggest that, with each successive lactation, the amount o f Cr that the newborn
would obtain from its dam would decrease. Research in this area is needed to determine
whether Cr supplementation to the dam, and subsequently to the calf, would be beneficial.
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Friel and co-workers (1985) conducted a study o f 103 infants and found that at three
mo of age 23% o f pre-term babies and 35% o f full-term babies failed to meet the minimum
recommended safe and adequate daily Cr intake. As already mentioned, marginal dietary
intakes o f Cr have been related to impaired glucose tolerance in some human population
groups.

Friel and co-workers (1985) suggested that' abnormalities in carbohydrate

metabolism, not infrequent in early post-natal life, may be related to sub-optimal Cr status.
Saner et al. (1980) conducted a study with newborn infants in which an intravenous
glucose tolerance test was performed before 24 h o f age, then gave Cr (250 fj.g CrCl3 in 2
ml o f tea), and then repeated the test approximately 13 h after the administration o f Cr. An
average glucose clearance rate o f 1.22% per min was observed (1.34 and .90% per min for
the Cr-supplemented and control group, respectively) among the infants when they were less
than 24 h old and an average clearance rate o f 2.67% per min was observed (2.58 and
2.04% per min for the Cr-supplemented and control group, respectively) among the infants
when they were about 37 h old. A significant increase in glucose clearance was observed
on the 2nd d o f life in both groups o f newborns. These authors concluded that the low
glucose clearance rate in the newborn, irrespective o f administered Cr, may be taken as
evidence that the active role o f Cr may be inadequate in the newborn. The lack o f precise
control of glucose homeostasis in the human neonate has been postulated to be a secondary
consequence o f either a decreased sensitivity to or a decreased resistance to insulin (Cowett
et al., 1983).
In adult monogastric animals, blood glucose and plasma insulin generally increase
following oral or intravenous glucose tolerance tests. In response to an influx o f glucose

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

21
into the blood stream, the body responds by inhibiting hepatic glucose production and
increasing the rate at which glucose is taken up by tissues, thereby avoiding the development
o f hyperglycemia (Unger, 1981).

Regulation o f glucose homoeostasis in newborns

however, may be less well developed, since evidence has shown that hepatic glucose
production is not normally suppressed following intravenous glucose tolerance tests in
infants (Cowett et al., 1983), dogs (Varma et al., 1973), and rats (Ferre et al., 1985; Issad
et al., 1987). Studies that have employed intravenous glucose tolerance tests to measure
glucose homeostasis in newborn infants (<48 h) have shown that low glucose clearance rates
characterize the 1st few d o f life (Baird and Farquhar, 1962; Bowie et al., 1963; Falorai et
al., 1974). A delay in pancreatic insulin release has been suggested as a primary reason for
the slowed rate o f glucose clearance (Saner et al., 1980). Insulin insensitivity appears to be
a common characteristic of newborns; however, the persistency o f this insulin insensitivity
also appears to vary among species. In human newborns, insulin sensitivity increases within
the 1st wk o f life (Baird and Farquhar, 1962; Bowie et al., 1963; Falomi et al., 1974), in rats
between the 2nd and 4th wk o f life (Issad et al., 1987), and in dogs between the 7th and 8th
wk o f life (Varma et al., 1973). Although, the mechanism(s) responsible for these changes
are unclear, it appears that a nutritional component may exist. For example, in the rat
experiment, an increase in insulin sensitivity coincided with the time that the pups were
weaned from a high-fat, low-carbohydrate diet (milk) to a high-carbohydrate, low-fat diet
(laboratory weaning diet; Issad et al., 1987). In this study, it was suggested that changes
in insulin sensitivity (in this case an increase) may be, to a degree, influenced by nutrition
(i.e., high fat vs. high carbohydrate diet) but that there was also a possible influence o f
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developmental state. Whether changes in insulin sensitivity are due to nutrition, stage of
development (i.e., age), or a combination o f the two, in the aforementioned monogastric
species, insulin sensitivity increases during the neonatal period.
Following consumption o f a meal, glucose is absorbed from the intestine similarly
in young ruminant (pre-weaned) and monogastric animals. Subsequently, glucose and
shortly thereafter insulin concentrations rise in the blood. However, as far as glucose
utilization is concerned, the tissues o f the young monogastric have a greater response to
insulin, as they can convert glucose to fatty acid at a high rate (this process provides a sink
for glucose disposal), whereas in the ruminant this capacity is very limited (Vernon and
Sasaki, 1991). In addition, the capacity to transport glucose across the plasma membrane
o f adipocytes is less in ruminants compared with nonruminants. Since, postprandial insulin
and glucose concentrations in intensively-fed calves have been suggested to become elevated
to the point that urinary spillage o f blood glucose is possible (Hostettler-Allen et al., 1994).
It would seem that if the tissues o f intensively-fed calves could be made more responsive to
insulin, glucose might potentially be used more efficiently.
To investigate this question, Kegley et al. (1997a) conducted a study with milk-fed
dairy calves from 1 to 10 wk o f age to determine if the insulin potentiating action of Cr
would increase or at least maintain insulin sensitivity as the calves became older. Chromium
was supplemented in a commercial milk replacer at 0.4 ppm as either CrCl3 or a Cr-nicotinic
acid complex. Chromium did not affect growth performance, urea-N, glucose before or
after (1 h) feeding, and cholesterol (3 h after feeding) on any o f the sampling d. Chromium
also did not affect glucose and insulin response patterns or glucose clearance rates in
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response to an IVGTT or following consumption o f milk replacer. However, based on the
glucose and insulin changes observed following an insulin injection, these authors concluded
that the tissues in the Cr-fed calves might have been more sensitive to insulin. Other
observations from this experiment, but reported in a separate paper (Kegley et al., 1996)
discussed the effects that supplemental Cr had on the immune system. Although most
responses were minimal, the calves fed the Cr-nicotinic acid complex supplemented-replacer
were observed to have a greater inflammatory response to an intradermal injection of
phytohemagglutinin injection than the control-replacer-fed calves.

Serum cortisol

concentrations following a challenge with an infectious bovine rhinotracheitis virus were
also lower in Cr-fed compared with control-fed calves. From this study, these authors
concluded that addition o f Cr to milk replacer may enhance immunity and, thus, increase
disease resistance in young calves.
The only other study conducted with ruminants in which the animals might be able
to be classified as neonates was conducted by Arthington et al. (1997). In this study, 3 mg
Cr/d of a high-Cr-yeast product was supplemented to a calf starter and fed to weaned (6 to
8 wk old) Holstein bull calves over the next S3 d. Supplemental Cr did not affect ADG or
rectal temperatures. On d 53 of the trial, calves were inoculated with bovine herpesvirus-1
and 24 h later blood and urine samples and rectal temperatures were collected at 6-h
intervals over the next 6 d. Cortisol, ACTH, plasma tumor necrosis factor-a, rectal
temperatures, and trace mineral excreted in the urine were not affected by Cr. These
authors concluded that Cr supplementation using high-Cr-yeast did not alter stress responses
o f young, weaned calves experimentally inoculated with bovine herpesvirus-1.
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Implications o f Chromium During Stress
Stress, in general, is the body’s response to a threat or demand (i.e., some stimuli)
arising from a new or changing situation where the bodies’ reaction to that stimulus disturbs
its normal physiological equilibrium and (or) homeostasis (Hadley, 1988; Guyton, 1991).
Two stages o f stress exist. During the initial stage, the alarm phase, the body mobilizes its
fight or flight defenses, either to resist the stress-causing factor or to adapt to it. In this
stage, the pituitary-adrenocortical system pours hormones into the bloodstream. The pulse
quickens, the lungs take in more oxygen to fuel the muscles, blood sugar increases to supply
added energy, and digestion slows. In stage two, the resistance stage, the body begins to
repair the incidental damage caused during the alarm stage. If the stressful situation is
resolved, the symptoms brought on by the stress will gradually subside. However, if the
stressful situation is not resolved vital organs can become affected which in turn may lead
to an increased risk o f disease or even death (Hadley, 1988; Guyton, 1991).
The initial hormonal response to stress is the release o f epinephrine and
norepinephrine. Although these hormones cause short-lived effects, only 20 to 30 s, they
increase gluconeogenesis and glycogenolysis in the liver and skeletal muscle, increase
lipolytic activity, and increase general metabolism (Hadley, 1988; Guyton, 1991). A variety
o f nonspecific stimuli can cause marked increases in the rate o f cortisol secretion by the
adrenal cortex (Hadley et al., 1988; Guyton, 1991). Cortisol, a glucocorticoid, promotes
gluconeogenesis but reduces glucose utilization (Guyton, 1991). The increased rate o f
gluconeogenesis coupled with a reduction in the rate o f glucose uptake by cells causes blood
glucose concentrations to rise. Although cortisol provides a positive benefit by suppressing
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the inflammatory response in the short-term (Guyton, 1991), elevated levels over prolonged
periods can impair immune response, such that relatively innocuous infections can escalate
to the point o f extreme morbidity (Goodman, 1988). During prolonged stress, fuels that
could be used to promote growth are no longer available, because they must now be used
to fight off an infection or repair damaged tissue.
Evidence from studies with humans and mice suggest that various physiological or
metabolic challenges (i.e., elevated intakes o f glucose, low protein diets, infection, strenuous
exercise, trauma) increase urinary excretion o f Cr (Pekarek et al., 1975; Borel et al., 1984;
Anderson et al., 1988). These findings have led some investigators to suggest that animals
must be under some form o f stress before a beneficial response from Cr supplementation will
be observed (Anderson, 1994b; Mowat, 1994). In livestock, stress has been clearly shown
to lead to reduced performance (Khansari et al., 1990).
Urinary Cr levels are recognized as an indicator o f Cr mobilization, because they
increase with the intensity and duration o f the stress (Anderson et al., 1990). The IVGTT
is the most commonly used diagnostic technique to measure the effects of Cr
supplementation on insulin effectiveness.

Although glucose loading increases Cr

mobilization, as demonstrated by greater urinary C r excretion, it is not nearly as great as
what is observed following physical trauma or strenuous exercise. Therefore, the amount
o f Cr lost in the urine may be dependent on or be an indication o f the degree o f stress
imposed (Anderson, 1994b).
Studies involving Cr supplementation to livestock that are under significant stress
are limited. Researchers have reported that stressed feeder calves (stress was transportation
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to a new facility) that received supplemental Cr had improved performance, reduced
morbidity, and improved humoral immune function (Chang and Mowat, 1992; MoonsieShageer and Mowat, 1993; Mowat et al., 1993; Wright et al., 1994; Kegley and Spears,
1995). In contrast, when non-stressed feeder calves were studied over longer feeding
periods, growth performance was not influenced by Cr supplementation (Chang and Mowat,
1992; Chang et al., 1995; Bunting et al., 1994, Mathison and Engstrom, 1995).
Some studies with stressed cattle have reported a decrease in serum cortisol
concentrations in Cr supplemented animals (Chang and Mowat, 1992; Moonsie-Shageer and
Mowat, 1993). Supplementation with 0, .2, .5, and 1 ppm Cr from a high-Cr yeast to
transit-stressed feeder calves resulted in a linear decrease in serum cortisol concentrations
during the 1st 28 d o f the experiment (Moonsie-Shageer and Mowat, 1993). Chang and
Mowat (1992) also reported that high-Cr yeast decreased serum cortisol concentrations in
transit-stressed steers after 64 d o f supplementation. By contrast supplementation o f a highCr yeast product to younger (6 to 8 wk old) weaned calves did not afreet cortisol
concentrations.
Physical, nutritional, and emotional stress are all possibilities in the neonatal calf.
Situations that may lead to chronic stress and consequently to elevated cortisol levels in the
young calf could include extremes in temperature (hot to cold), nutrition (transition from
liquid to dry fed diet), disease, surgery, restraint and almost any type o f trauma. Cortisol
decreases immune system functions (Kelley, 1988; Muneer et al., 1988).
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Implications o f Chromium on Immune Function
In laboratory animals, supplemental Cr has been shown to increase resistance to
pulmonary infections (Schroeder et al., 1964) and decrease mortality rates associated with
experimentally induced acute hemorrhages (Mertz and Roginski, 1969). In feedlot cattle
supplemental Cr was shown to reduce haptoglobin (an acute phase protein that increases
during trauma or inflamation) concentrations (Wright et al., 1995) and increase humoral
immune response and reduce morbidity (Change and Mowat, 1992; Moonsie-Shageer and
Mowat, 1993; Mowat et al., 1993; Wright et al., 1995). In newly arrived transit-stressed
calves, supplemental C r reduced the incidence o f bovine respiratory disease (Mowat et al.,
1993; Lindell et al., 1994). Supplemental Cr has also been reported to decrease morbidity
(and) or reduce the number o f relapses in newly arrived feeder steers in some studies
(Moonsie-Shageer and Mowat, 1993; Mowat et al., 1993; Wright et al., 1994), but not
other studies (Chang and Mowat, 1992; Chang et al., 1995).
Dairy cows fed supplemental Cr during the periparturient period (6 wk pre to 16 wk
postpartum) had increased in vitro concanavalin A stimulated lymphocyte blastogenic
responses and prevented a decrease in blastogenic response that were observed in controls
at two wk prepartum (Burton et al., 1994). Chromium supplementation with high-Cr yeast
did not alter the stress responses of calves experimentally inoculated with bovine
herpesvirus-1 (Arthington et al., 1997).
Kegley et al. (1996) reported that a greater inflammatory response to intradermal
phytohemagglutinin (used to evaluate cell-mediated immune response) was observed in
milk-fed calves receiving supplemental Cr as either a Cr-nicotinic acid complex or CrCl3.
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In these same calves, it was also observed that following an infectious bovine rhinotracheitis
virus challenge, the calves that received the Cr-nicotinic acid complex tended to have lower
body temperatures compared with the CrCl3-fed and control-fed calves. Serum cortisol
concentrations were also lower in the Cr-fed compared with the control-fed calves.
Lymphocyte blastogenic response to phytohemagglutinin and pokeweed mitogen were not
affected by Cr. These authors concluded that Cr supplementation may enhance immunity
and, thus, increase disease resistance in young calves. Specific high affinity insulin receptors
have been found on bovine peripheral blood mononuclear cells (Mcbride et al., 1989) and
the functional capacity o f cultured bovine peripheral blood mononuclear cells has been
found to be affected by insulin (Burton et al, 1993). Some studies, but not others, and some
immunological measurements, but not all, suggest that Cr is probably important in immune
modulation. Speculation would seem to suggest that the action o f Cr on immune responses
are similar to what has been suggested for its effect on carbohydrate and lipid metabolism.
That is by improving the insulin sensitivity of immune cells. Glucose uptake by immune cells
is insulin dependent. Therefore improving insulin’s effectiveness may ensure that energy
(i.e., glucose) is available so that the immune cells can carry-out their required functions.
It is also known that as insulin sensitivity decreases, such as with a diabetic individual,
immune responsiveness also decreases (Mangrum and Bakris, 1997).

ChromiumEffects on Growth Performance
Since the early sixties, growth performance (i.e., rate o f gain, feed intake, feed
efficiency) has been measured in laboratory animals fed a variety o f diets supplemented with
inorganic and organic Cr sources. Supplemental Cr to typical laboratory rat and mice diets
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have been reported to increase rates o f gain (Schroeder et al., 1963a,b; Schroeder, 1965;
Schroeder 1966; Mertz and Roginski, 1969). In addition, Schroeder (1965) compared
growth curves o f Cr-fed and control-fed rats and mice and concluded that the largest
increases seemed to occur around weaning. In studies that have investigated whether there
was an interaction between supplemental Cr and sex, most reported no effect o f sex
(Schroeder et al., 1963b; Schroeder, 1965; Schroeder 1966), although one study (Mertz and
Roginski, 1969) reported the supplemental Cr enhanced the growth rate o f females to a
greater degree than that o f males. Two more recent reports failed to find any beneficial
improvements on performance in rats fed supplemental Cr (Hasten, 1994; Bush, 1997).
Why some studies conducted with laboratory animals have reported that supplemental Cr
improves some performance criteria and other similarly conducted studies have failed to find
a difference is not readily apparent. However, one theory that has been suggested is that
these inconsistencies may be because o f an individual animal's Cr status, prior to the time
supplementation was begun. That is, animals that are already adequate in Cr may not show
a response to supplemental Cr. Mooradian and Morely (1978) suggested that improvements
from Cr supplementation will be most likely to take place only in Cr-deficient subjects. In
addition, the use o f different Cr sources and the bioavailability o f those sources may also be
a contributing factor to the lack o f consistency between studies.
Chromium effect on performance criteria have also been variable in studies
conducted with livestock. As suggested for the laboratory animals, initial Cr status may be
a contributing factor. Furthermore, formulating Cr-free diets for livestock is less practical
than for laboratory animals. Therefore it is even more difficult to ensure that the only
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source o f Cr that the animal receives is that which is part o f the treatment. Possibly as a
result o f these limitations, Cr supplementation studies conducted with livestock have been
shown to either result in slight increases (Chang and Mowat, 1992; Page et al., 1993; Chang
et al., 1995), or have no effect (Bunting et al., 1994; Chang and Mowat, 1992; EvockClover et al., 1993; Kitchalong et al., 1995; Lindemann et al., 1995; Page et al., 1993;
Chang et al., 1995) on growth performance.
In pigs, some studies have reported greater growth rates in Cr-fed compared with
control-fed (Page et al., 1993; Van Heugten and Spears, 1994) while others have reported
no effect o f supplemental Cr (Evock-Clover et al., 1993; Ward et al., 1994). In newly
arrived market-transit calves, Chang and Mowat (1992) reported that addition o f .4 ppm Cr
as a high-Cr yeast to the ration improved ADG (average daily gain) by 30% and feed
efficiency by 27% during the 1“ 28 d after arrival in the Cr-fed calves compared with
control-fed calves that did not receive an oxytetracyciine injection, but not compared with
the control-fed calves that received an oxytetracyciine injection within 48 h after arrival.
Moonsie-Shageer and Mowat (1993) showed a linear relationship between Cr intakes (0 to
1 ppm) and growth performance responses during the initial 28 d after arrival o f transitstressed feeder steers. However, in this study, performance responses were again similar
after calves were switched from receiving to finishing rations. In stressed feeder calves,
supplementation o f Cr at .5 ppm to the ration as an amino acid-Cr chelate has also been
reported to improve ADG (Mowat et al., 1993).

However, in this study, growth

improvements were attributed to fewer morbid calves in the Cr supplemented group.
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Supplementation o f .37 ppm Cr as chromium picolinate to nonstressed calves fed
com-cottonseed hull basal diets over a 56-d period did not affect ADG, DMI, or feed
efficiency (Bunting et al., 1994). Likewise, no differences were observed on gain, intake,
or efficiency when supplementing .2 ppm Cr from high Cr yeast to growing (70 d) and
finishing (68 d) cattle (Chang et al., 1992). In lambs receiving high concentrate rations,
addition o f Cr as Cr picolinate was also reported to have no effect on ADG or feed intake
(Kitchalong et al., 1995).

In calves fed milk alone through the initial 9-wk o f life,

supplementation with Cr as CrCl3 or a Cr nicotinic acid complex did not affect rate o f gain
or feed efficiency compared with control-fed calves (Kegley et al., 1997a).
M ost reports on changes in body composition in response to addition o f
supplemental C r to rations have been reported in studies conducted with pigs, as opposed
to ruminants. In pigs the more commonly observed effects o f Cr supplementation on
carcass changes seem to be increased longissimus muscle area and decreased tenth rib fat
thickness (Page et al., 1993; Smith et al., 1994; Lindemann et al., 1995).

In sheep,

Kitchalong et al. (1995) also reported that Cr picolinate reduced tenth rib fat thickness and
also showed there was a tendency for a decrease in pelvic frit. In cattle, Chang et al. (1992)
and Mathison and Engstrom (1995) reported that Cr supplementation did not affect any o f
the carcass measurements taken; however, Claeys et al. (1994) did report higher quality
grades for Cr-fed compared with control-fed steers.
Chromium Effects on Milk Production
Glucose uptake by the mammary cells appears to be independent o f the action o f
insulin (Brockman, 1986). Therefore, it would appear that there would be little benefit from
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Cr supplementation on milk production. However, emerging data from lactation studies
suggests that supplemental Cr may increase milk yield during early lactation (Yang et al.,
1996, Besong et al., 1996). Although it is not clear how supplemental Cr may increase milk
yield in early lactation, one possibility is that a slight reduction in the rate o f mobilization o f
fatty acids from adipose tissue may simply help stabilize hepatic fat metabolism, reduce
hepatic ketogenesis, and perhaps allow feed intake to increase more rapidly after calving.
However, only in the Besong et al. (1996) study was the increase in milk yield accompanied
by increased feed intake. Yang and co-workers (1996) postulated that increased milk yield
may be the result of the indirect effects o f Cr on gluconeogenesis. Subiyatno et al. (1996)
in early lactation heifers and Sano et al. (1996) in stressed rams showed that, following an
i.v. propionate loading test, the conversion o f propionate to glucose increased in those
animals receiving supplemental Cr. This suggests that Cr may, by some yet unknown
mechanism, increase gluconeogenesis. A more direct hypothesis for the increase in milk
production might be that Cr promoted the activity o f the insulin-like growth factor (IGF)
receptors, because IGF receptors have a structural and functional homology similar to that
of insulin receptors (Yang et al., 1996). Subiyatno and co-workers (1996) showed trends
for increased circulating IGF-1 in Cr supplemented, early lactation cows following a
propionate challenge.
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CHAPTER m
PERFORMANCE AND METABOLIC RESPONSES OF
PRE- AND POST-WEANING HOLSTEIN CALVES
SUPPLEMENTED WITH CHROMIUM PICOLINATE
Introduction
Chromium is well established as an essential trace element for man and laboratory
animals (Anderson, 1987; Mertz, 1993). Chromium appears to be an integral component
o f a molecular complex known as the glucose tolerance factor which facilitates the cellular
binding and action o f insulin. There is increasing evidence that Cr may be a required
nutrient in livestock diets.

Supplemental Cr has improved glucose tolerance and has

improved a number o f production parameters in swine (Page et al., 1993; Amoikon et al.,
1995). In ruminants, positive production responses to supplemental Cr seem to depend
upon the presence o f stressors, such as "market-transit" stress (Chang and Mowat, 1992;
Moonsie-Shageer and Mowat, 1993; Mowat et al., 1993) or early lactation (Subiyatno et
al., 1996). Supplemental Cr has had only modest effects on glucose tolerance or other
indices o f carbohydrate metabolism in functional ruminants (Bunting et al., 1994; Kegley
and Spears, 1995; Kitchalong et al., 1995; Subiyatno et al., 1996). However, functional
ruminants derive little glucose from intestinal absorption and the role o f insulin in these
animals is perhaps less well defined than in the nonruminant (Brockman, 1986).
Because glucose is absorbed in comparatively large quantities in the milk-fed
ruminant, the importance o f insulin to glucose homeostasis is analogous to that o f the
nonruminant. In addition, there is evidence that milk-fed calves become insulin resistant
with age, resulting in exaggerated postfeeding elevations in insulin and glucose in the blood
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(Hostettier-Allen et al., 1994). Under these conditions, there is the potential for urinary
spillage o f blood glucose and reduced efficiency. In addition, Grutter and Blum (1991)
reported that insulin secretory mechanisms may not be fully developed in young calves.
Therefore, it seems plausible that neonatal calves would be more metabolically responsive
to Cr than adult cattle. The limited data that are available with milk-fed calves were not
conclusive regarding the effects of supplemental Cr on carbohydrate metabolism (Kegley
et al., 1997a). The study described herein was conducted to more clearly delineate the
effects o f supplemental Cr on carbohydrate metabolism in conventionally-fed calves from
birth through weaning.
Materials and Methods
Animals and Feeding. Forty-two Holstein calves bom at the campus dairy farm in
Baton Rouge, were used in an experiment approved by the Institutional Animal Care and
Use Committee o f the LSU Agricultural Center. Although the calves were bom over a fivemonth period (August 23 to December 5,1994), the experimental period for each calf lasted
from 4 d to around 8 wk (d 53 ± 3) of age. Calves were removed from their dams within
24-h o f birth, weighed, and individually housed in 2.5-m2 hutches with a 2.3-m2 wire
enclosure attached to the hutch. During the first 3 d after birth, calves received colostrum
only (1.9 liters twice daily) and were trained to drink from buckets. Any colostrum not
voluntarily consumed was fed by bottle or esophageal feeding tube. Calves readily drinking
from buckets and showing no apparent health problems at 3 d o f age were divided into sex
and birth date peer groups, and then randomly assigned to treatment (11 male and 10 female
calves per treatment). Treatment consisted o f diets either without (control) or with 1 ppm
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supplemental chromium (Cr). Chromium was supplied as chromium picolinate (CrP; 12%
Cr; Nutrition 21, San Diego, CA).
Beginning on d 4 and until 5 wk o f age (weaning), calves received a commercial milk
replacer with a guaranteed analysis o f 22% CP and 15% fat (Nurstrate®, Moorman’s, Inc,
Quincy, IL ). Each calf received 250 g o f DM as milk replacer in 1600 mL o f 40+1° C tap
w ater at 0800 and 1600 daily until weaning. Chromium picolinate is poorly soluble in
water, hence, to ensure complete consumption, the entire daily allotment was suspended in
15% o f the evening feeding and given via a bottle until calves were weaned. On d 4 and 5
o f age, Cr-supplemented calves received a priming dose o f 21 mg o f C r daily and from 6 d
o f age until weaning they received 4.2 mg/d o f Cr. After calves were weaned CrP, in a
dextrose carrier, was supplemented in the starter.
On the morning following collection o f wk 2 blood samples calves were offered a
commercial calf starter with a guaranteed analysis o f at least 16% CP and 2% fat (Purina®
commercial calf starter/grower (coarse) BVT 60; Purina Mills, Inc, St. Louis, MO). Starter
intake was recorded and fresh feed offered at each feeding. When a calf had consumed all
o f its starter between feedings, an additional 100 g o f starter was offered. All calves were
weaned at around 5 wk o f age at an average starter intake of .96 kg/d.
Sample Collection and Metabolic Challenges. Body weight (BW) measurements
were taken shortly after birth and at noon when calves were around 2, 4, and 8 wk old. At
1, 2, 3, 4 and 5 wk o f age, blood was collected immediately before (prefeeding) and 2 h
after (postfeeding) the evening meal by jugular venipuncture into 7-mL evacuated tubes
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containing potassium oxalate and sodium fluoride (Sherwood MedicaL, St. Louis, MO).
Postfeeding blood sampling was discontinued for the last eight calves added to the study.
Metabolic challenges were conducted on half the calves. An i.v. glucose tolerance
test (TVGTT) was conducted at the end o f the 2nd wk of life (the d prior to starter access)
and during the 8th wk o f life to measure the calves abilities to clear a glucose load. A
propionate loading test (PLT) was also conducted on the same calves during the 8th wk of
life to measure the effects o f Cr supplementation on gluconeogenic potential. The IVGTT
was performed 4 h after the morning milk feeding at 2 wk o f age and after an overnight fast
(16 h) at 8 wk o f age. Calves were fitted with 14-G jugular catheters (Quik-Cath®; Baxter
Healthcare, Deerfield, EL) and were allowed at least 1 h of rest prior to the IVGTT. The
IVGTT consisted o f infusing a glucose solution (500 mg/kg o f BW in a 50% w/v solution
in sterile saline) as an i.v. bolus dose over a 30- to 60-s interval. Prior to infusion of
glucose, one blood sample was drawn (0 min) and then glucose was administered (1 mL/kg
BW) i.v. through the catheter. Blood was then drawn at 10, 15,20, 30, 40, 50 and 60 min
relative to glucose infusion. Following completion of the IVGTT conducted at 8 wk o f age,
calves were given access to water only during a 2-h rest period prior to beginning the PLT.
The PLT consisted o f a pulse i.v. infusion o f propionate (3 mmol o f Na-propionate/kg BW
as a 1.84 M solution in sterile saline) over a 2-min interval. Blood samples were collected
prior to and 5, 10, 15, 20, 40, 60, 90, and 120 min relative to propionate infusion. To
ensure that none o f the infusion solutions remained in the catheter sheath, following infusion
o f glucose or Na-propionate, sterile saline (5 mL) was flushed through the catheter.
Catheter patency was maintained with 6% sodium citrate in sterile saline.
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Blood Processing and Analyses. Blood samples were placed in ice immediately after
withdrawal and were centrifuged within 1 h at 3,000 x g for 10 min at 4°C to obtain plasma.
Plasma was harvested and stored at -15°C. Weekly blood samples were analyzed for
plasma glucose, insulin, and nonesterified fatty acids (NEFA) concentrations in the 0 and
2 h samples, whereas plasma cortisol and IGF-1 concentrations were determined only in the
prefeeding samples. Commercial kits were used in the colorimetric determination o f plasma
glucose (Sigma Tech. Bull. No. 315; Sigma Chemical, St. Louis, MO) and NEFA (NEFA-C
Kit; Wako Chemicals USA, Richmond, VA).

Plasma cortisol was determined by a

commercial kit (Cortisol RIA Kit No.DSL-2000; Diagnostic Systems Laboratories Inc.,
Webster, TX.). Plasma insulin and IGF-1 were determined by RIA as described by Sticker
et al. (1995). For blood samples collected during the PLT, propionate was precipitated as
a Na salt from deproteinized plasma as described by Ryan (1980). The propionate salt was
resuspended in water and subjected to standard gas chromatography (Shimadzu GC-17A,
Shimadzu Scientific Instruments, Inc., Columbia, MD) with samples corrected to 100%
recovery using 2-ethybutyric acid as an internal standard.
Statisrical Methods and Calculations. Glucose and propionate clearance rates were

computed for each calf following the IVGTT or PLT, respectively (Kaneko, 1989).
Intervals used to compute glucose clearance rate were 15 to 30 min and 10 to 40 min for
the IVGTT and PLT, respectively. The interval to compute propionate clearance rate was
5 to 20 min for the PLT. Changes in plasma glucose in response to the IVGTT and PLT
were further evaluated by computing area under the response curves (AUC) relative to basal
levels using trapezoidal geometry.
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Data for initial BW, starter intake, and kinetic analysis o f metabolite challenges were
analyzed by least squares ANOVA and PROC GLM o f SAS (SAS®, 1989). The model was
a factorial including treatment, sex and treatment by sex interaction. Analysis o f final and
intermediate BW measurements and feed efficiency included birth weight as a covariable.
Data for prefeeding and postfeeding hormone and metabolite concentrations were analyzed
as a split-plot. In the whole plot, treatment, sex and treatment by sex were tested against
calf (treatment x sex) means square. In the sub-plot, calf age (wk) and all interactions o f
age with treatment and sex were tested against residual mean square.

The PROC

UNIVARIATE procedure o f SAS (SAS®, 1989) was used to test for normality and a
Shapiro-Wilks test value o f 0.1 was selected for rejection o f the null hypothesis. When
normality was rejected, data transformation was used to achieve normality and transformed
values analyzed. Means are reported in original units and all statistical analyses were
conducted using the GLM procedure o f SAS (SAS®, 1989). Aside from the previously
mentioned blood samples that were not collected there was one CrP-fed heifer in which only
performance data was collected and one CrP-fed bull in which only its weekly blood variable
measurements and performance data through wk 2 were used.
Results and Discussion
Performance. Twenty-two male and twenty female Holstein calves entered the trial
at 4 d o f age. Aside from minor, controllable bouts o f scours that occurred primarily before
weaning, calves were healthy throughout the trial. Calves averaged 38.5 ± 4 kg at birth and
gained an average o f 27.8 ± 6.5 kg over the 8 wk trial. As expected, rate o f weight gain
was influenced by the age o f the calf (P - .0001). Average daily gain was lowest while
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calves were fed milk only (. 17 ± . 13 kg/d/calf) and increased exponentially ( r = 1) over the
ensuing 2 to 3-wk weighing intervals. Over the initial 2-wk interval that calves had access
to starter, calves gained an average o f .36 ± . 16 kg/d, and over the final 2- to 3-wk interval
calves gained an average o f .77 ± . 13 kg/d. Over the entire trial, calves gained an average
o f .50 ± . 1 kg/d and .47 ± .05 kg o f BW was gained per kg o f DM intake. Starter intake
was minimal (less than .22 kg/d) between 2 and 3 wk o f age, then steadily increased (P =
.0001) throughout the remainder o f the experiment. Based on three-day-averages, starter
intakes (as-fed) o f .45, .68, .91, 1.36, and 1.84 kg/d were reached at 28 ± 4, 32 ± 4, 35 ±
4, 39 ± 4, and 44 ± 5 d o f age, respectively.
In calves, rate o f gain characteristically increases exponentially throughout the first
several months o f life (Roy, 1980). Reported ADG can also be influenced by differences
in feeding regimes and differences in the time frames used to report daily gains. These
inherent and imposed differences between studies make comparing rates o f gain from one
study to the next difficult. Through the first 90 d o f life, a desirable rate o f gain for dairy
herd replacements has been suggested to be about .875% o f birth weight daily or about .42
kg/d (Roy, 1980). This is about .08 kg/d less than observed in the current trial. Holstein
calves fed milk alone and milk plus grain and (or) hay over the initial 28 d o f life have been
reported to gain .26 kg/d and .53 kg/d, respectively (Quigley et al., 1991). Estimates o f
growth rates in Holstein calves during the first several months o f life have ranged from .39
to .66 kg/d across a variety o f feeding regimes (Doppenberg and Palmquist, 1991; Quigley
et al., 1991; Quigley and Bernard, 1992; Kegley et al., 1997a).
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The effects o f Cr supplementation and sex on rate o f gain were analyzed over three
intervals: 1) milk-fed only, 2) starter plus milk, and 3) over the entire trial. For all the
intervals investigated ADG did not differ (P > .10) between calves fed control or Crsupplemented milk replacers or between bulls and heifers (Table 3 .1). However, when
calves received milk alone, there was a tendency for bulls given supplemental Cr to gain
more weight and for heifers given supplemental Cr to gain less weight compared to controlfed calves (treatment x sex; P = . 15; Table 3.1). This tendency was not evident once calves
began receiving starter (treatment x sex; P = .27); however, over the entire trial, bulls given
supplemental Cr gained more weight and heifers gained less weight than control calves
(treatment x sex; P = . 10; Table 3.1). Kegley et al. (1997a) reported that supplementation
with either organic or inorganic Cr had no effect on rate o f gain or feed efficiency in
Holstein bull calves fed milk alone during the first 9 to 10 wk o f life. In older calves,
supplemental Cr has been reported to improve performance in some studies (MoonsieShageer and Mowat, 1993; Mowat et al., 1993) but not others (Bunting et al., 1994; Kegley
and Spears, 1995). Starter intakes did not differ between treatments or sexes (P > .10;
Table 3 .1). When calves were fed only milk, all calves received the same amount o f DM
daily. It is possible that, because bulls were slightly (P = .17; Table 3.1) larger than heifers
at birth, bulls may have been more nutrient deficient than were the heifers.
Plasma Metabolites and Hormones. Regardless o f calf age, sex did not affect (P >
.10) pre- and postfeeding blood metabolite concentrations; hence, only the effects o f dietary
treatment and age are presented in Tables 3.2 and 3.4. With the exception o f prefeeding
NEFA (below), there were no interactions (P > . 10) between treatment and age for any o f
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Table 3.1. Least squares means for BW gain and starter intake in calves supplemented with chromium picolinate.
Treatment
P > F1

Chromium

Control
Item

SEM

Treatment

Sex

Treatment
x Sex

38.2

1,36

.83

.17

.22

.18

.12

.04

.40

.99

.15

.53

.53

.48

.03

.76

.94

.10

.60

.63

.66

.62

.04

.52

.90

.27

.92

1.04

1.09

1.02

.08

.36

.75

.25

Bulls

Heifers

Bulls

Heifers

11

10

11

10

40.5

36.9

38.5

week 0 to 23

.15

.21

week 0 to 8

.47

week 2 to 84

nJ
Initial BW, kg
BW gain, kg/d

Starter intake, kg of DM/d
(week 2 to 8)

'Probability o f greater F-value.
^For one bull calf in the CrP treatment only its initial and week 2 BW data were used.
3Period during which calves received only milk.
'Period during which calves received milk plus grain (week 2 to 5) and grain only (week 5 to 8).
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the prefeeding or feeding-response plasma metabolite concentrations measured in this
experiment (Tables 3.2 and 3.4).

Generally, the plasma glucose response to feeding

increased until calves were about 3 wk o f age and then declined to wk 5 o f age (age effect;
P = .003; Table 3.2). This age-related pattern was more obvious in Cr-supplemented calves;
however, glucose responses in calves fed the control milk replacer were relatively consistent
from one wk to the next (treatment x age trend; P = . 12; Table 3.2). The physiological
relevance o f this observation relative to the effect o f Cr on insulin function is not clear.
Chromium had no independent effects (P > .10; Table 3.2) on pre- or postfeeding
concentrations o f glucose or insulin. When intensively-fed veal calves consumed a normal
meal, plasma glucose concentrations have been observed to rise above the assumed renal
threshold for urinary glucose excretion in calves (Hostettler-Allen et al., 1994). The renal
threshold for calves has been estimated at between about 8 and 10 mM (Wijayasinghe et al.,
1984; Scholz and Hoppe, 1987; Hostetder-AUen et al., 1994). Hostettler-Allen et al. (1994)
concluded that urinary glucose loss was probably only a transient phenomenon, but
represented a potential source o f lost energy that could contribute to reduced feed utilization
and growth performance; however, in their study, ADG and gain:feed ratio by calves was
not visibly diminished. In our study, plasma glucose concentrations rarely exceeded 8 mM
and then, only at 1 wk o f age.
In contrast to plasma glucose, plasma insulin increased by 38% from 1 to 5 wk o f
age (age effect, P = .09; Figure 3.1), although the magnitude o f the plasma insulin response
to feed was not affected (P = . 19; Table 3.2) by the age o f the calf. The gradual divergence
o f plasma glucose and insulin concentrations with age (Figure 3.1) could have at least two
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Table 3.2. Least squares means for plasma glucose and insulin concentrations
at weekly intervals prior to (Pre) and 2 h after feeding (Post)1
____________in calves supplemented with chromium picolinate.____________
Insulin

Glucose
Treatment2

Age,
weeks

Pre

Post

---- (mM)-----

change3
(%)

Pre4

Post4

----- (ng/ml)------

change5
(%)

Control
1
2
3
4
5

5.31

6.43

21.3

.28

1.97

554.8

(5.1, 5.5)6

(6.1,6.8)

(13, 30)

(.21, .37)

(1.3,2.9)

(297, 955)

5.21

6.51

24.2

.30

1.01

221.0

(5.0, 5.4)

(6.1,6.9)

(16,34)

(.23, .40)

(.7, 1.5)

(87,435)

4.90

6.25

26.0

.34

1.41

177.1

(4.7,5.1)

(5.9,6.6)

(17. 36)

(.25, .44)

(1.0,2.1)

(60,366)

4.62

5.94

26.7

.33

1.58

374.0

(4.4,4.9)

(5.6,6.3)

(18, 37)

(-25, .44)

(1.1,2.3)

(182,675)

4.55

5.58

19.6

(4.3,4.8)

(5.2,5.9)

(12.28)

.36
(21,

.47)

1.84

378.3

(1.3,2.7)

(185, 682)

Chromium
1
2
3
4

5.37

6.04

8.4

.30

1.41

326.2

(5.1, 5.6)

(5.7,6.4)

(2, 16)

( 22, .40)

(.9,2.1)

(148,613)

4.99

6.26

25.1

.26

.93

218.8

(4.7, 5.2)

(5.9, 6.6)

(16, 35)

( 20, .35)

(.6, 1.4)

(82,442)

4.70

6.27

34.0

.31

1.28

296.3

(4.4,4.9)

(5.9,6.8)

(24,46)

(.23, .42)

(-8,2.0)

(124, 580)

4.48
(4 2 ,

5

4.7)

6.06

33.1

.37

1.34

223.2

(5.7,6.5)

(23,45)

(.28, .50)

(.9,2.0)

(81,460)

4.57

5.73

20.9

.45

2.40

432.7

(4.3,4.8)

(5.3, 6.1)

(12,31)

(.33, .61)

(1.6, 3.7)

(206, 800)

.44

.72

.98

.84

.74

.72

.0001

.002

.003

.09

.004

.19

.69

.55

.12

.70

.67

P > F7
Treatment
Age
Treatment
xage
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(Table con’d.)
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‘For prior to feeding (Pre) variables, n = 21 and 20 calves for control and chromium means,
respectively, and for 2 h after feeding (Post) and percentage change variables, n = 17 and
16 calves for control and chromium means, respectively
2There were no interactions o f treatment or age with sex (P > . 10).
’For statistical analysis, the percentage change in glucose original values were transformed
by raising the original values to the .4 power.
4For statistical analysis, the Pre and Post insulin original values were transformed by taking
the natural log o f the original values.
’For statistical analysis, the percentage change in insulin original values were transformed
by raising the original values to the . 1 power.
6With the exception o f Pre and Post glucose variables, all means are based on analysis o f
transformed data; consequently, the lower and upper 95% confidence limits for each mean
are given in parentheses.
’Probability o f a greater F-value.
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Figure 3.1. W eekly prefeeding concentrations o f plasm a glucose and insulin.
Solid line = glucose; dash line = insulin.
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Figure 3.2. W eekly prefeeding and 2 hours after feeding concentrations o f
plasm a nonesterified fatty acids (NEFA). Solid line = basal; dash line = 2
hours after feeding; square = control; circle = chrom ium picolinate.
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unique developmental components. First, insulin insufficiency appears to be a common
characteristic o f neonates, as pancreatic insulin release is limited for the 1st few d or wk o f
life. For example the capacity to clear a load of glucose increases measurably within the 1st
wk o f life in humans (Baird and Farquhar, 1962; Bowie et al., 1963; Falomi et al., 1974),
between the 2nd and 4th wk of life in rats (Issad et al., 1987), and between the 7th and 8th
wk o f life in dogs (Varma et al., 1973). Similarly, Grutter and Blum (1991) reported the
mechanisms o f insulin secretion may not be fully developed in young calves. Secondly, there
is evidence suggesting that tissue sensitivity to insulin is adequate in the young preruminant
animal but begins to decline as the rumen begins to develop (Weekes et al., 1983; M etcalf
and Weekes, 1990; Grutter and Blum, 1991; Sano et al., 1991). Thus, the data from the
present experiment may indicate that, as the calves become older, more insulin was required
to maintain a declining homeostatic level o f glucose. That is, calves may have gradually
become less insulin sensitive with age.
By the time the second IVGTT was conducted at 8 wk o f age, prefeeding plasma
glucose concentrations were some 20% lower than during the first IVGTT conducted at 2
w k o f age (Table 3.3). It was interesting that glucose clearance rates were almost 40%
faster at 2 wk o f age compared with 8 wk o f age when the calves were fully functional
ruminants. Although not statistically testable, this may again indicate that the calves were
becoming less insulin sensitive. At 2 wk of age, heifers had higher (P = .10) glucose
clearance rates than bulls; however, this effect had all but disappeared (P = .67) by 8 wk o f
age. Supplemental Cr had no influence on (P > .10) on basal plasma glucose, glucose
clearance rate or AUC at either 2 or 8 wk o f age. When Cr was supplemented as Cr-
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Table 3.3. Least squares means for kinetic response variables during i.v. infusions of glucose and propionate
Sex

Treatment
Item

Bulls

Heifers

10

11

.64

4.76

.38

.96

161

29

4.02

3.91

Glucose clearance rate, %/min

1.59

Glucose AUC, min-mM

Control

Chromium

10

11

Basal glucose concentrations, mM

5.05

4.90

.22

Glucose clearance rate, %/min

2.24

2.22

Glucose AUC, min-mM

145

Basal glucose concentrations, mM

P > F2

SEM

P > F2

5.18

.22

.19

1.76

2.70

.38

.10

.71

173

134

29

.36

.22

.73

3.80

4.13

.22

.31

1 16

.19

.12

1.32

1.43

.19

67

301

320

23

.57

314

308

23

.84

Basal propionate concentrations, mM

.57

.35

.10

.15

.42

.50

10

.61

Propionate clearance rate, %/min

7.02

8.24

.85

.33

7.75

7.51

.85

.84

Basal glucose concentrations, mM

3.92

3.54

.26

.30

3.64

3.82

.26

.63

90

70

20

.51

20

139

21

.001

n

SEM

IVGTT3
2 weeks of age

8 weeks of age

PLT4
8 weeks of age

Glucose AUC, min-mM

(Table con’d.)
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'There were no (P > . 10) treatment interactions.
Probability o f a greater F-value.
3Kinetic criteria from i.v. glucose tolerance test (IVGTT): basal concentrations immediately prior to challenges; clearance rate computed
from 15 to 30 min after glucose challenge and area under the response curve (AUC) from 0 to 60 min.
4Kinetic criteria from propionate loading test (PLT): basal concentrations immediately prior to challenge; propionate clearance rate calculated
from 5 to 20 min after propionate infusion and glucose area under the response curve (AUC) from 0 to 60 min.
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nicotinate or CrCl3, glucose clearance rate during an IVGTT was not affected in 9-wk old
Holstein bull calves fed only milk (Kegley et al., 1997a) or in feeder calves (Kegley and
Spears, 1995). In contrast, glucose clearance rate during an IVGTT was 40 and 47% faster
in steers and heifer feeder calves respectively, when the calves were supplemented with Crpicolinate (Bunting et al., 1994).
During the PLT, basal levels o f propionate and glucose in the blood were similar (P
> . 10) for all calves (Table 3.3). Supplemental Cr affected (P > . 10) neither the propionate
clearance rate nor the blood glucose response (glucose AUC) to the PLT. Although the
heifers and bulls cleared their propionate loads at similar rates (P = .33), heifers had a much
greater (P = .001) plasma glucose response to the propionate challenge than did bull calves.
When combined with the finding o f greater glucose clearance rates during IVGTT by heifers
at 2 w k o f age, this finding may indicate that there are innate differences in glucose
metabolism between males and females, at least within the Holstein breed.
Plasma NEFA concentrations, measured both prior to and 2-h after feeding, declined
with age in all calves (P = .0001; Table 3.4). However, the magnitude o f the increase in
blood NEFA concentrations following milk replacer consumption became much greater as
the calves grew older (age effect; P = .002; Table 3.4). It is worth noting that plasma
NEFA concentrations typically decrease in most animals following consumption o f meal.
This is largely because o f insulin’s actions to decrease lipolysis and increase reincorporation
o f fatty acid into adipocytes. Chilliard (1993) noted that NEFA concentrations in ruminants
receiving a high level o f fat averaged 13% greater than the mean o f control groups.
Chilliard postulated that circulating NEFA concentrations become elevated because o f
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Table 3.4. Least squares means for plasma nonesterified fatty acids (NEFA), cortisol, and
insulin-like growth factor-1 (IGF-1) concentrations at weekly intervals prior to (Pre) and
^h^fte^fe^in^Post2M n^dvessu£glem ait^w itJ^hronuun^icolinat^^^^^^
NEFA
Treatment2

Age,
weeks

Pre3

Post3

— (mM) —

change3
(%)

Cortisol

IGF-1

Pre3

Pre3

-------- (ng/ml)---------

Control
1
2
3
4
5

.25

.29

27.8

5.92

8.87

(.20, ,30)4

(.25, .33)

(1.9, 60.4)

(4.45, 7.87)

(7.8, 10.0)

.15

.22

58.4

2.37

9.13

(.12, .18)

(.19, .25)

(27.3,97.1)

(1.78, 3.15)

(8.0, 10.4)

.10

.22

99.7

.92

9.38

(-08, .12)

(.19, .25)

(59.2, 150.5)

(.68, 1.23)

(82,10.7)

.12

.18

59.8

.70

10.99

(.10,-15)

(.16, .21)

(28.4, 98.9)

( 53, .93)

(9.6, 12.6)

.09

.20

128.1

.58

15.23

(.07, .11)

(17, .22)

(80.1, 188.9)

( 44, .78)

(13.3, 17.4)

Chromium
1

2

3
4
5

.20

.22

23.4

7.00

7.90

(.16, .24)

(.19, .25)

(-1.6,54.9)

(5.23, 9.38)

(6.9, 9.1)

.13

.19

69.4

2.43

8.91

(-11,.16)

(.16, .22)

(31.1, 118.9)

(1.81,3.25)

(7.7, 10.3)

.12

.20

44.0

1.12

10.34

(.10, .15)

(.17,-22)

(13.7,82.4)

(.83, 1.51)

(9.0, 11.9)

.08

.16

92.5

.89

12.34

(.07, .10)

(-14,-18)

(52.1, 143.8)

(.66, 121)

(10.7, 14.2)

.09

.18

117.5

.69

16.45

(.07, .11)

(.16, -21)

(69.6, 178.8)

(-51. .93)

(14.3,18.9)

.12

.01

.72

.40

.80

.0001

.0001

.0002

.0001

.0001

.04

.62

.25

.96

.42

P > F5
Treatment
Age
Treatment x
age

(Table con’d)
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‘For prior to feeding (Pre) variables, n = 21 and 20 calves for control and chromium means,
respectively, and for 2 h after feeding (Post) and percentage change variables, n = 17 and
16 calves for control and chromium means, respectively.
2There were no interactions o f treatment or age with sex (P > . 10) except for basal NEFA
concentrations (treatment x age x sex; P = .05).
3For statistical analysis, the original values for all variables were transformed by taking the
natural log o f the original values.
4A11 means are based on analysis o f transformed data; consequently, the lower and upper
95% confidence limits for each mean are given in parentheses.
’Probability o f a greater F-value.
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incomplete removal o f free fatty acids into tissue adipocytes following the action o f
lipoprotein lipase on chylomicrons and lipoproteins. The milk replacer used in this study
contained 15% fat (DM basis) which would be some five times greater than the level o f fat
typical o f a post-weaning ruminant diet. Compared with control calves, prefeeding plasma
NEFA were lower in calves given Cr-supplemented milk replacer in the first wk o f life;
however, because blood NEFA declined more rapidly in control calves, calves in the tw o
treatments had similar prefeeding plasma NEFA concentrations by 5 wk o f age (treatment
x age; P = .04; Figure 3.2). When measured 2-h after feeding, plasma NEFA concentrations
from 1 to 5 wk o f age were lower for calves fed Cr-supplemented compared with the
control milk replacer (. 19 vs. .22 mM; P = .01; Table 3.4). Supplemental Cr has reduced
blood lipid concentrations in humans and laboratory animals (Doisy et al., 1976; Liu and
Morris, 1978; Anderson et al., 1988; M ertz, 1992; Mertz, 1993), as well as in ruminants
(Samsell and Spears, 1989; Bunting et al., 1994; Kitchalong et al., 1995; Yang et al., 1996).
The mechanism o f action o f Cr on lipid metabolism is not well understood. However, M ertz
(1993) suggested that the primary hypolipidemic effects o f organic Cr may be simply
attributable to the aforementioned effect o f insulin in decreasing lipolysis and increasing
reincorporation o f fatty acids into adipocytes.
Concentrations o f plasma cortisol were not affected (P > . 10) by Cr supplementation
or sex o f the calves; however, by 5 wk o f age, plasma cortisol concentrations were about
10% o f the concentrations observed at 1 wk o f age (age effect; P = .0001; Table 3.4). This
is consistent with what has previously been reported for calves (Massip et al., 1977) and
human infants (Wittekind et al., 1993), where concentrations have been observed to reach
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baseline adult concentrations by 2 to 3 wk of age. Cortisol levels could have an important
role in the stress-susceptible neonate because, somewhere between the point o f entry o f
glucose into the cells and its final degradation, cortisol directly delays the rate o f glucose
utilization (Guyton, 1991). Hence, it is not unrealistic that Cr, via improved binding o f
insulin to its receptors, might help normalize blood glucose and (or) NEFA concentrations
in the presence o f high cortisol concentrations.
In chronically stressed cattle, Bennet et al. (1989) reported that high cortisol levels
lead to hyperglycemia and elevated free fatty acids. In the short-term increased cortisol can
provide a positive benefit by suppressing inflammatory responses; however, over prolonged
periods, immune responses can be impaired such that relatively innocuous infections can
escalate to the point o f extreme morbidity (Goodman, 1988). Moonsie-Shageer and Mowat
(1993) first reported that addition o f Cr to the feed o f “market-transit” stressed feeder
calves lowered circulating cortisol concentrations, reduced morbidity, and increased growth
during the first month after being transported from market to the experimental site;
however, similarly conducted studies have not been able to confirm this response (Mowat
et al., 1993; Wright et al., 1994; Chang et al., 1995). The finding that Cr did not affect
cortisol concentrations in the present experiment is in agreement with findings that have
been reported in sheep (Kitchalong et al., 1995; Forbes et al., 1998) and calves (Bunting et
al., 1994; Kegley and Spears, 1995).
Concentrations o f plasma IGF-1 were not affected (P > . 10) by Cr supplementation
or sex o f the calves; however, by 5 wk o f age, plasma IGF-1 concentrations had almost
doubled in the calves (age effect; P = .0001; Table 3.4). In dairy heifers fed whole milk
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through weaning (8 wk o f age) and given access to hay and starter beginning at 3 and 4 wk
o f age, respectively, IGF-1 concentrations were observed to gradually increase from wk 4
to 12 and after wk 12 decreased (Hugi and Blum et al., 1997). To our knowledge, this is
the first report o f IGF-1 concentrations in growing calves receiving supplemental Cr.
Addition o f Cr to the rations o f lactating dairy cows did not afreet IGF-1 concentrations
(Burton et al., 1995); however, in yearling ewes, there was a trend for increased IGF-1
concentrations in lambs fed Cr-picolinate (Forbes et al., 1998).

Growth hormone

concentrations were not affected by Cr supplementation in feeder calves (Bunting et al.,
1994). The effects o f growth hormone on nutrient metabolism and tissue accretion are
largely mediated through IGF-1. Among the specific effects o f growth hormone are an
increased rate o f protein synthesis and increased mobilization o f fatty acids from adipose
tissue (Guyton, 1991; Granner, 1996). Concentrations of IGF-1 in the blood o f farm
animals are positively correlated with developments o f skeletal mass and with the
composition and rate o f body tissue deposition (Olsen et al., 1981; Buonomo et al., 1987;
Anderson et al., 1988). Changes in circulating concentrations o f plasma IGF-1 are primarily
regulated by energy balance and secondarily by protein in most animals (Underwood et al.,
1986; Ronge et al, 1988; Ronge and Blum, 1989).
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CHAPTER IV
PERFORMANCE AND METABOLIC RESPONSES OF PRE-WEANED HOLSTEIN
CALVES FED A BASAL OR A HIGH LEVEL OF FAT IN MILK REPLACERS
SUPPLEMENTED WITH CHROMIUM NICOTINATE
Introduction
Chromium (Cr) is well established as an essential trace element for man and
laboratory animals (Anderson, 1987; Mertz, 1993). Chromium appears to be an integral
component o f a molecular complex known as the glucose tolerance factor which facilitates
the cellular binding and action of insulin; however, the exact mechanism(s) at the
receptor/cellular level has not been clearly defined (Mertz et al., 1974; Govindaraju et al.,
1989; Mertz, 1993). There is increasing evidence that Cr may be a required nutrient in
livestock diets.

Supplemental Cr has improved glucose tolerance and a number o f

production parameters in swine (Page et al., 1993; Amoikon et al., 1995). In ruminants,
positive production responses to supplemental C r seem to depend upon the presence of
stressors, such as, “market-transit” stress (Chang and Mowat, 1992; Moonsie-Shageer and
Mowat, 1993; Mowat et al., 1993) or early lactation (Subiyatno et al., 1996). Supplemental
C r has been reported to improve immune responses and (or) disease resistance in cattle
(Burton et al., 1993; Kegley et al., 1996; Kegley et al., 1997b). Supplemental Cr has had
only modest effects on glucose tolerance or other indices of carbohydrate metabolism in
functional ruminants (Bunting et al., 1994; Kegley and Spears, 1995; Kitchalong et al.,
1995; Subiyatno et al., 1996).
Because glucose is absorbed in comparatively large quantities in the neonatal
ruminant, the importance o f insulin to glucose homeostasis is analogous to that o f the
55
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nonruminant. Grutter and Blum (1991) reported that insulin secretory mechanisms may not
be fully developed in young calves. In addition, there is evidence that milk-fed calves
become insulin resistant with age, resulting in exaggerated postprandial elevations in insulin
and glucose in the blood (Hostettler-Allen et al., 1993, 1994). Under these conditions, there
is the potential for urinary spillage o f blood glucose and reduced efficiency. Therefore, it
seems plausible that neonatal calves would be more metabolically responsive to Cr than
adult cattle. The limited data that are available with pre-weaned calves are not conclusive
regarding the effects o f supplemental Cr on carbohydrate metabolism (DePew et al., 1995;
Kegley et al., 1997a).
Supplemental fat has been reported to increase insulin resistance in lactating cattle
(Palmquist and Moser, 1981). In addition, high-fat milk replacers have been reported to
elevate blood glucose concentrations in Holstein calves (Wijayasinghe et al., 1984). In our
previous study with pre-weaned calves fed a conventional milk replacer (Chapter 3),
supplemental Cr elicited reductions in circulating NEFA, but no apparent effect on glucose
homeostasis (i.e., glucose tolerance/insulin sensitivity). In the present study, pre-weaned
calves were fed milk replacers with either a conventional or an elevated level of fat. Our
objectives were to determine: 1) whether supplemental Cr would have a measurable effect
on insulin sensitivity, if greater insulin resistence is induced with added fat; 2) whether
supplemental Cr would continue to reduce blood lipid levels when a higher level of dietary
fat is eaten.
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Materials and Methods
Animals and Dietary Treatments. Thirty-four Holstein calves (21 bulls and 13
heifers; 38.5 ± 6 kg initial BW), bom at the campus dairy farm in Baton Rouge, were used
in an experiment approved by the Institutional Animal Care and Use Committee o f the LSU
Agricultural Center. Although the calves were bom over a four-month period (November
to February, 1996), the experiment period for each calf was from 4 d o f age to around 5 wk
o f age.

Calves were removed from their dams within 24-h o f birth, weighed, and

individually housed in 2.5-m2 calf hutches with a 2.3-m2 wire enclosure attached to the
hutch. For the initial 3 d o f life, calves received colostrum only (1.9 liters twice daily) and
were trained to drink from buckets. Any colostrum not voluntarily consumed was fed by
bottle or esophageal feeding tube. Calves readily drinking from buckets and showing no
apparent health problems at 3 d o f age were divided within birth date and sex peer groups
and then randomly assigned to one o f four dietary treatment groups.
Dietary treatments, arranged in a 2 x 2 factorial, consisted o f milk replacer with
either a basal level o f fat (15% o f DM as fat; BF) or a high level o f fat (22% o f DM as fat;
HF) fed either without (control) or with supplemental chromium (Cr). A commercial milk
replacer with a guaranteed analysis of 22% CP and 15% fat (Nurstrate®, Moorman’s, Inc.,
Quincy, IL ) was used for the BF replacer, whereas the HF replacer was formulated using
85% o f Nurstrate® and 15% Super calf-kit® (Merrick’s, Inc., Middleton, WI), a
commercial high-energy milk replacer supplement with a guaranteed analysis o f 7%CP and
60% fat. The estimated daily nutrient consumption (based on guaranteed analysis) from the
BF and HF replacers for a 36.3 kg calf at birth are presented in Table 4.1. Both replacers
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Table 4.1. Estimated daily nutrient consumption1 from the basal2 and high-fat3
^ ^ ^ ^ ^ ^ ^ ^ m ill^ e £ la c e r ^ fb i^ ^ ^ je |^ ja lfa lj)ir tfr ^ ^ ^ ^ ^ ^ ^ ^ ^ ^
Milk Replacers
Estimated

Basal Fat

High Fat

Crude Protein, g/d

114.4

114.6(97.4, 17.2)4

Fat, g/d

78.0

126.2(107.3, 18.9)

327.6

339.2 (288.3, 50.9)

Carbohydrate, g/d

520
580 (493, 87)
Total, g/d
‘Based on guaranteed analysis.
N urstrate® , Moorman’s, Inc, Quincy, IL.
385% Nurstrate plus 15% Super calf-kit®, Merrick’s, Inc, Middleton, WI.
4In parentheses are grams provided by Nurstrate and Super Calf-kit, respectively.
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were reconstituted to 15% DM using 40 ± 1°C tap water and calves receiving the BF and
HF replacers received 1.4% and 1.6%, respectively, o f replacer DM per kg o f BW. The HF
replacer was formulated such that calves fed the HF replacer consumed about 60% more
fat but similar amounts o f carbohydrate and protein as calves fed the BF replacer (Table
4.1). The milk replacer was given in two equal feedings at 0800 and 1600 daily throughout
the experiment. Chromium was provided as Cr nicotinate (13.7% Cr, LONZA, Inc.,
Fairlawn, NJ). On the 1st 2 d o f the experiment (d 4 and 5 o f age), Cr was included at 5
ppm (DM basis) as a priming dose and for the remainder o f the experiment Cr was included
at 1 ppm (DM basis).
On the morning following collection o f the wk 2 blood samples, calves were offered
a commercial calf starter with a guaranteed analysis o f at least 16% CP and 2% fat (Purina®
commercial calf starter/grower (coarse) BVT 60; Purina Mills, Inc, St. Louis, MO). Starter
intake was recorded and fresh feed offered at each feeding. When a calf consumed all o f its
starter between feedings, an additional 100 g o f starter was offered. Body weight (BW)
measurements were also obtained at noon when calves were around 2 and 5 wk o f age.
Blood Sample Collection and Metabolic Challenges. At 1,2, 3, 4 and 5 wk o f age,
blood was collected immediately before (prefeeding) the 1600 feeding by jugular
venipuncture into 7-mL evacuated tubes containing potassium oxalate and sodium fluoride
(Sherwood Medical, St. Louis, MO). Starter was not removed prior to collection o f
prefeeding blood samples collected at 3, 4, and 5 wk o f age. When calves were around 2
and 5 w k o f age, blood samples were also collected by venipuncture prior to and .5, 1, 2,
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3, and 4 h after the 1600 replacer feeding. Starter was removed at 1200 when blood
samples were collected relative to the 1600 replacer feeding, when calves were 5 wk o f age.
Around 5 wk o f age, an IVGTT was conducted to measure the calves abilities to
clear a glucose load and an epinephrine challenge was conducted to study the relative
magnitude o f NEFA release and subsequent reincorporation into adipose tissue. The
IVGTT was performed after an overnight fast (16 h). Average starter intake for the 3 d
preceding and on the d immediately preceding the IVGTT were .71 and .42 kg, respectively.
Calves were given their full daily allotment o f milk replacer at the evening feeding following
the challenges. At 0700, calves were fitted with 14-G jugular catheters (Quik-Cath®,
Baxter Healthcare, Deerfield, EL) and were allowed at least 1 h o f rest prior to the IVGTT.
The IVGTT consisted of infusing a glucose solution (500 mg/kg o f BW; 50% w/v solution
in sterile saline) as a bolus dose over a 30- to 60-s interval. Prior to infusion of glucose, one
blood sample was drawn (0 min) and then glucose was administered (1 mlVkg BW) i.v.
through the catheter. Blood was then drawn at 10, 20, 30, 40, 50, 60, 90 and 120 min
relative to the glucose infusion.
During the 2-h period between completion o f the IVGTT and the epinephrine
challenge, the calves were only allowed access to water.

The epinephrine challenge

consisted o f a bolus i.v. infusion o f epinephrine (2 y.g Epinephrine-HCl/kg BW). Two pre
infusion blood samples were drawn (- 20 and 0 min) and then epinephrine administered (.02
mL/kg BW) i.v. through the catheter. Blood samples were then drawn at 10, 20, 40, 60,
80, 100 and 120 min relative to propionate infusion. To ensure that none o f the infusion
solutions remained in the catheter sheath, following infusion o f glucose or epinephrine-HCl,
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sterile saline (5 mL) was flushed through the catheter. Catheters were maintained with 6%
sodium citrate in sterile saline.
Blood Analyses. Plasma was analyzed for glucose (Sigma Tech. Bull. #315, 1989),
cholesterol (Sigma Tech. Bull. # 352, 1992), and triacylglycerol (Sigma Tech. Bull # 334,
1995) spectrophotometrically using commercial kits (Sigma Chemical, St. Louis, Mo.).
Plasma NEFA concentrations were determined using a commercial enzymatic procedure
(NEFA-C Kit, ACS-ACOD Method; Wako Chemicals, USA, Richmond, VA). Plasma
insulin was determined by RIA as described by Sticker et al. (1995) and plasma cortisol was
determined by a commercial kit (Cortisol RIA Kit No. DSL-2000; Diagnostic Systems
Laboratories Inc., Webster, TX.). Samples were assayed in duplicate and measurements
resulting in errors greater than 5% were re-analyzed.

The exception was that the

measurement o f blood triacylglycerol and NEFA from the epinephrine challenge were not
replicated.
Statistical Methods and Calculations. Clearance rates and area under the response
curve (AUC) for glucose and insulin were computed for each calf following the IVGTT
(Kaneko, 1989).

To further evaluate carbohydrate metabolism a computer modeling

procedure which has been used to evaluate glucose effectiveness (SG) and insulin sensitivity
(S;) in humans was also employed (Watanabe et al., 1995; Bergman, 1997). In general, SG
is a measure o f insulin-independent glucose disappearance from the circulation, whereas S{
is a measure o f insulin-dependent glucose clearance. The computer model was originally
developed to evaluate SG and Sf, among other variables, based on glucose and insulin
concentrations obtained at specific intervals in response to an i.v. infusion o f glucose,
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followed by an infusion o f insulin that is also given at a specific time. We did not employ
the full minimal model procedure, nonetheless, the model was able to provide an estimate
o f Sj from the glucose and insulin concentrations obtained from the IVGTT. The validity
the S} values obtained and degree o f fit by the model was evaluated by J. C. Lovejoy
(Lovejoy, personal communication).
Data for initial BW, ADG, starter intake, kinetic analysis o f metabolite challenges
and relative to feeding responses were analyzed by least-squares ANOVA and PROC GLM
o f SAS (SAS®, 1989). The model was a factorial including Cr level, fat level, and Cr by fat
level interaction. Data for prefeeding (weekly) and responses relative to milk feedings (2
and 5 wk o f age) for hormone and metabolite concentrations were analyzed as a split-plot.
In the whole plot, Cr level, fat level, and Cr by fat level were tested against calf (Cr x fat
level) means square. In the sub-plot, the effect o f time and all interactions o f time with Cr
and fat level were tested against the residual mean square. The PROC UNIVARIATE
procedure o f SAS (SAS® 1989) was used to test for normality and a Shapiro-Wilks test
value o f 0.1 was selected for rejection o f the null hypothesis. When normality was rejected,
data transformation was used to achieve normality and transformed values analyzed. Means
are reported in original units and all statistical analyses were conducted using the GLM
procedures o f SAS (SAS® 1989).

Results and Discussion
Background.

In preweaning, conventionally-fed Holstein calves consuming a

commercial 15% fat milk replacer supplemented with chromium picolinate, we observed
NEFA concentrations were reduced (DePew et al., 1995). Although none o f the indices
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used to evaluate whether Cr had influenced glucose tolerance and (or) insulin effectiveness
were significant, our interpretation o f the results, as a whole, led us to believe that calves
receiving supplemental Cr may have maintained insulin sensitivity longer (age). Kegley
(1997a) and co-workers observed that supplementation o f Cr to the diets o f intensively-fed
Holstein calves consuming a 20% fat milk replacer had no influence on most o f the indices
used to evaluate whether Cr affected glucose tolerance and (or) insulin effectiveness.
However, based on the glucose response, following an i.v. infusion o f insulin, these
investigators stated, “tissues from calves that were fed Cr might have been more sensitive
to the insulin, or the insulin might have had a longer lasting effect in these calves”. Because
our study showed reduced NEFA concentrations, and both o f the previously mentioned
studies hinted toward insulin sensitivity being maintained longer in Cr-fed calves, we
included dietary flit level as a second factor under the premise that calves fed the higher level
o f fat would have greater circulating blood lipid concentrations and become more insulin
insensitive at an earlier age. This would enable us to develop a clearer picture o f whether
the hypolipidemic effects and improved glucose tolerance/insulin sensitivity effects, that
have been attributed to the supplementation o f Cr in humans with non-insulin dependent
diabetes, (Wallach, 1985; Mertz, 1993) would also cause similar metabolic changes in the
conventionally-fed, pre-weaned dairy calf.
Performance. Other than minor, controllable bouts o f scours, calves were healthy
throughout the experiment.

The rates o f gain achieved by the calves in the current

experiment were comparable with and, in most instances, better than other investigators
have reported for calves of similar ages and when similar feeding regimes were employed
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(Doppenberg and Palmquist, 1991; Quigley et al., 1991; Quigley and Bernard, 1992; Kegley
et al., 1997a).

No dietary interactions (P > .10) were observed among any o f the

performance criteria; therefore, only treatment effects are reported (Table 4.2). Chromium
supplementation did not affect (P > . 10) ADG, ADG:DMI, or starter intake during any o f
the feeding periods analyzed; however, while calves were fed milk alone there was a
tendency for ADG (P =. 16) and ADGrDMI (P = . 16) to be greater in Cr-fed compared to
control-fed calves. In pre-weaned Holstein calves, similar responses were observed when
Cr-picolinate was supplemented in the diet o f conventionally-fed calves (DePew et al.,
1995) and when CrCl3 or a Cr-nicotinic acid complex was supplemented in the diet o f
intensively-fed calves (Kegley et al., 1997a). In young (6 to 8 wk o f age) weaned calves,
no difference in ADG over a 51-d period was observed between control-fed calves and
calves fed a high-Cr yeast supplemented starter (Arthington et al., 1997). Studies including
supplementation o f various Cr compounds to the diets o f ruminating calves (Bunting et al.,
1994; Wright et al., 1994; Chang et al., 1995; Kegley and Spears, 1995; Mathison and
Engstrom, 1995) and lambs (Fomea et al., 1994; Kitchalong et al., 1995; Forbes et al.,
1998) have also reported no effect on rate o f gain, DMI, or feed efficiency.
In ruminants, the greatest potential for supplemental Cr to increase performance
(i.e., growth and milk production) would seem to be in animals in which metabolic demand
is high (i.e., transit/market, intensive handling, reintroduction with a new group o f animals,
early lactation). Supplementation of various Cr compounds to the diets o f “market-transit”
stressed feeder calves had no effect on growth performance in some studies (Wright et al.,
1994; Chang et al., 1995; Kegley and Spears, 1995; Mathison and Engstrom, 1995). In
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Table 4.2. Effect o f chromium nicotinate (CrNIC) and fat level on body weight gain
^ ^^ ^ ^ n d ^ starteM n tak jeL n ^ g ^ ^ ean ^ ^ o n v en tio n all^ ^ E to lsteii^ alv es^ ^ ^ ^
Treatment

Fat Level
P-value2for
treatment

SEM

P-value2for
fat level

38.6

1.5

.88

.17

.23

.03

.10

.63

.48

.50

.04

.60

.02

.28

.36

.40

.02

.26

.40

.04

.16

.32

.38

.04

.32

.51

.50

.03

.85

.51

.50

.03

.77

week 0 to 5

.46

.48

.02

.63

.47

.47

.02

.94

Starter intake,
kg ofDM/d5

.38

.42

.03

.37

.39

.40

.03

.85

Item

SEM

Basal

High

16

18

.48

38.3

.03

.16

.50

.04

.36

.39

week 0 to 2

.31

week 2 to 5

Control

CrNIC

17

17

37.7

39.3

1.5

week 0 to 23

.18

.23

week 2 to 54

.48

week 0 to 5

a
Initial BW. kg
ADG, kg

ADG:DML
kg/d

'There were no (P > .10) dietary treatment interactions,
^ o b ab ility o f a greater F-value.
3Milk-fed only.
4Starter plus milk-fed.
5Week 2 to 5.
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contrast, others reported improvements in some growth performance criteria, although, in
such cases, the effects were generally limited to the first few wk after the calves arrived
(Chang and Mowat, 1992; Moonsie-Shageer and Mowat, 1993; Mowat et al., 1993;
Mathison and Engstrom, 1995; Kegley et al., 1997b). Why Cr supplementation results in
improved growth performance, in some but not other similarly conducted experiments, is
a m atter o f speculation. However, an animal’s individual Cr status prior to receiving
supplemental Cr, the bioavailability and biological activity o f Cr compounds supplemented,
and stressor variables, are frequently suggested as contributing factors. An explanation for
the “stressor” association appears to stem from studies in man and laboratory animals that
showed that as demand and (or) intensity o f the demand increases, the body responds by
increasing its mobilization of stored Cr and, once mobilized, any Cr that is not used, is
excreted (Anderson et al., 1993).

The likelihood o f observing an effect from Cr

supplementation under such a situation may therefore be heightened, because there is greater
potential for Cr body stores to become depleted faster than can be replenished by the Cr that
is available in the base feed stuffs.
In the current experiment, a colostrometer was used to ensure that only high quality
colostrum (> 70 mg o f immunoglobulins/mL) was fed, and care was taken to ensure it was
fed at recommended levels and within the recommended time (Donovan, 1992; Morrill,
1992).

Although immunoglobulin concentrations were not measured in the calves, it

appears that adequate immunoglobulin transfer was achieved and adequate nutrients were
supplied to the calves, such that health problems were minimized.

Speculatively, it is

possible that, because only healthy calves were initially included in the current experiment,
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and because only minor, controllable bouts of scours were observed throughout the
experiment, minimal demands (beyond normal growth requirements) were placed on this
group o f young calves. As a result, no significant improvements in growth performance
were detectable. Whether Cr supplementation would provide greater benefit for calves
raised under more commercial dairy farm settings needs to be investigated as Heinrichs
(1994) and co-workers reported that 75.5% o f dairy calves on US farms receive less than
adequate amounts o f colostrum within the first 24-h o f birth. In addition, this statement
assumes that calves were fed an acceptable quality colostrum (minimum o f 50 mg o f
immunoglobulins/mL; Scott and Fellah, 1983) that ensured that adequate levels o f
immunoglobulins were received by each calf.
Fat level of the replacer did not affect (P > . 10) ADG, ADG.DML, or starter intake
over the entire 5 wk experimental period or during the period after the calves were given
access to starter. However, while calves were fed milk alone, ADG (P = . 10) was greater
in calves fed the HF replacer compared with those fed the LF replacer. Wijayasinghe et al.
(1984) reported that intensively-fed calves receiving high (30%) versus low-fat (3%) milk
replacers gained weight at similar rates from 1 to 3 wk o f age; however, after the 3rd wk,
calves receiving the high-fat milk replacer gained weight faster than calves receiving the
low-fat milk replacer. Scibilia (1987) and co-workers reported that ADG increased linearly
with fat level (10%, 17.5%, 25%) o f the o f the milk replacer during the first 3 wk o f life,
although the response was more dramatic when calves were housed at temperatures below
compared with within the zone o f thermal neutrality.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

68
Weekly Changes in Plasma Metabolites and Hormones. Irrespective o f dietary
treatments, from 1 to 5 wk o f age, plasma concentrations for glucose and NEFA decreased
(P = .001; Figures 4 .1 and 4.3) and plasma concentrations for triacylglycerol and cholesterol
increased (P = 0001; Figures 4.4 and 4.5). Over this period, plasma insulin concentrations
were more stable; although, there was a slight tendency ( P = .17; Figure 4.2) for an
increase. For glucose, NEFA and insulin, these age related changes agree with a similarly
conducted experiment from our lab (DePew et al., 1995). In addition, other researchers
have also observed similar age related changes for all the aforementioned metabolites and
hormones (Shannon and Lascelles, 1966; Doppenberg and Palmquist, 1991; Quigley, et al.,
1991; Quigley and Bernard, 1992; Kuehn et al., 1994; Hugi and Blum, 1997).
Except for cholesterol (see below), no three-way interactions (P > . 10) among Cr,
fat level, and age were observed for the blood variables measured (Figures 4 .1, 4.2, 4.3, 4.4,
4.5), and no interactions (P > .10) between Cr and fat level were observed for the blood
variables when averaged across the 5 wk. In addition, few interactions o f Cr with age or
fat with age were observed; therefore, sampling dates were combined and only the
independent effects o f Cr and fat level, for the various blood variables, are shown (Table
4.3).
At 1 wk o f age, plasma insulin concentrations were similar for calves in all dietary
treatment groups, however, by wk 2, and lasting through wk 5, a gradual divergence was
observed with plasma concentrations tending to be lower for calves fed Cr-supplemented
replacer compared with those fed control replacer (Cr x age trend; P = . 11; Figure 4.2). In
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Figure 4.1. Weekly concentrations o f plasm a glucose. Calves were fed
m ilk replacer that contained either 15% (basal) o r 22% (high) fat without
(control) o r with supplemental chrom ium nicotinate (CrNIC). Solid line
= basal fat; dash line = high fat; square = control; circle = CrNIC.
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Figure 4.2. Weekly concentrations o f plasm a insulin. Calves were fed
m ilk replacer that contained either 15% (basal) or 22% (high) fat without
(control) o r w ith supplemental chrom ium nicotinate (CrNIC). Solid line
= basal fat; dash line = high fat; square = control; circle = CrNIC.
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Figure 4.3. W eekly concentrations o f plasm a nonestenfied fatty acids.
Calves w ere fed m ilk replacer that contained either 15% (basal) or 22%
(high) fat w ithout (control) or with supplem ental chromium nicotinate
(CrNIC). Solid line = basal fat; dash line = high fat; square = control;
circle = CrNIC.
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Figure 4.4. W eekly concentrations o f plasm a triacylglycerol. Calves were
fed milk replacer that contained either 15% (basal) or 22% (high) fat
without (control) o r w ith supplemental chrom ium nicotinate (CrNIC).
Solid line = basal fat; dash line = high fat; square = control; circle =
CrNIC.
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Figure 4.5. W eekly concentrations o f plasma cholesterol. Calves were
fed m ilk replacer that contained either 15% (basal) or 22% (high) fat
without (control) o r with supplemental chromium nicotinate (CrNIC).
Solid line = basal fat; dash line = high fat; square = control; circle =
CrNIC.
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Table 4.3. Effect o f chromium nicotinate (CrNIC) and fat level on prefeeding plasma
glucose, insulin, nonesterified fatty acids (NEFA), triacylglycerol (TG), and
cholesterol concentrations in pre-weaned, conventionally-fed Holstein calves1*23.
Treatment
Item

Fat Level
P-value4 for
treatment

P-value4for
fat level

Basal

High

16

18

.47

5.26
(5.09, 5.43)

5.46
(5.30, 5.63)

.09

.66
(.42, .94)

.30

.78
(.52, 1.09)

.73
(.48,1.02)

.78

.11
(.10,.13)

.13
(.11,-14)

.10

.11
(.09, .12)

.13
(12,.15)

.01

TG.
mg/dl8

19.6
(15.7,23.9)

17.8
(14.1,21.9)

.53

18.1
(14.3,22.4)

19.3
(15.5,23.4)

.67

Cholesterol.
mM9

2.14
(1.92,2.38)

2.39
(2.15,2.63)

.14

2.18
(1.94,2.42)

2.35
(2.13,2.58)

.28

Control

CrNIC

17

17

Glucose,
mM

5.32
(5.15, 5.49)5

5.40
(5.24, 5.57)

Insulin.
ng/ml6

.86
(.59, 1.17)

NEFA
mM7

n

‘Mean o f samples taken at 1 ,2 ,3 ,4 , and 5 weeks o f age.
2Irrespective o f age there were no (P > . 10) dietary treatment interactions.
3There were no interactions with age (P > 10) except for plasma NEFA (fat x age; P =
.0001) and cholesterol (treatment x fat x age; P= .01) concentrations.
Probability o f a greater F-value.
sWith the exception o f glucose, all means are based on analysis o f transformed data;
consequently, the lower and upper 95% confidence limits for each mean are given in
parentheses.
6For statistical analysis, plasma insulin concentrations were transformed by raising the
original values to the .7 power.
P o r statistical analysis, plasma NEFA concentrations were transformed by taking the natural
log o f the original values.
*For statistical analysis, plasma triacylglycerol concentrations were transformed by raising
the original values to the .5 power.
*For statistical analysis, plasma cholesterol concentrations were transformed by raising the
original value to the .7 power.
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contrast, plasma glucose concentrations in the Cr-fed and control-fed calves declined at a
similar rate from wk to wk (P = .99; Figure 4.1). The lack o f a Cr treatment difference for
plasma glucose coupled with the divergence in plasma insulin between Cr-fed and controlfed calves suggests that insulin sensitivity may have been maintained longer in Cr-fed calves.
In mid-gestating sows fed diets supplemented with Cr-picolinate, no differences in plasma
glucose concentrations were observed (Lindemann et al., 1995). However, they did observe
lower insulin and insulin to glucose ratios in the Cr-fed compared with the control-fed sows
and interpreted this as evidence that Cr supplementation improved insulin action. In the
present experiment, no Cr or interaction of Cr by age effects (P > . 10; data not shown) were
observed for plasma insulin to glucose ratio; however, when the ratios were averaged across
the 5 wk, the ratio was numerically but not significantly smaller (. 14 vs. . 19; P = . 17; data
not shown) for the Cr-fed calves compared with the control-fed calves. In agreement with
our findings, Kegley et al. (1997a) reported that neither supplemental CrCl3 nor a Crnicotinic acid complex affected prefeeding plasma glucose concentrations in milk-fed
Holstein calves when there were 28 or 56 d old. In the aforementioned study, insulin was
not reported for d 28 o r 56; however, when calves were 9 to 10 wk old, plasma insulin
concentrations (6 h after the preceding meal) were lower in Cr-fed compared with controlfed calves; again, plasma glucose concentrations were unaffected. This observation tends
to agree with the present experiment, such that, C r did not induce any change in plasma
glucose concentrations, but plasma insulin concentrations (8 to 10 h after the preceding
meal) tended to be lower in Cr-fed compared with control-fed calves.
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The decline in plasma NEFA concentrations from wk to wk was similar between Crfed and control-fed calves (Cr x age; P = .51; Figure 4.3). Bunting et al. (1994) also
reported supplementing Cr, as Cr picolinate, in the ration o f ruminating steers and heifers
for a period of 8 wk, did not affect plasma NEFA concentrations (Bunting et al., 1994). In
contrast, ruminating lambs, fed diets supplemented with Cr picolinate, had lower plasma
NEFA concentrations at 2, 7, and 11 wk (Kitchalong et al., 1995) and 11 and 22 d (Forbes
et al., 1998) after supplementation was initiated, compared with control-fed lambs. Studies
with ruminant and nonruminant animals alike have typically observed that supplemental Cr
tends to either reduce (Samsell and Spears, 1989; Ward et al., 1995 DePew et al., 1995;
Kitchalong et al., 1995; Amoikon et al., 1995; Ward et al., 1997; Forbes et al., 1998) or
have no effect on plasma NEFA concentrations (Bunting et al., 1994; Ward et al., 1995
Besong et al., 1996; Yang et al., 1996; DePew et al., 1996). Therefore, observing that
plasma NEFA concentrations (averaged across the five wk) were greater (P = . 10; Table
4.3) in Cr-fed compared with control-fed calves was not expected.
Over the weekly sampling dates, plasma cholesterol concentrations in calves fed Crsupplemented replacer did not differ (P = .93) from those o f calves fed control replacer;
however, there was a Cr by fet by age effect (P = .01; Figure 4.5). This latter effect seemed
more apparent while calves received only milk. In essence, calves fed the Cr-supplemented,
HF replacer had higher plasma cholesterol concentrations compared with calves fed the
control, HF replacer, whereas, calves fed the Cr-supplemented, BF replacer had lower
plasma cholesterol concentrations compared with calves fed the control, BF replacer. The
cholesterol-lowering ability o f organic Cr complexes has been shown in both monogastrics
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(Mertz, 1993; Page et al., 1993), and ruminants (Bunting et al., 1994; Kitchalong et al.,
1995), but again this response is not always observed (Ward et al., 1997; Forbes et al.,
1998). Kegley et al. (1997a) reported that supplementing Cr as either CrCl3 or a Crnicotinic acid complex in the milk replacer fed to milk-only-fed calves did not affect
postfeeding (3 h) serum cholesterol concentrations at any time during the initial 9 to 10 wk
o f life.
Neither C r nor Cr by age effects (P > .10; Figure 4.4) were observed for plasma
triacylglycerol concentrations.

Similar observations have been reported in lambs

(Kitchalong et al., 1995; Forbes et al., 1998) and pigs (Lindemann et al., 1995). To our
knowledge, supplementing Cr to livestock has not been observed to affect plasma
triacylglycerol concentrations. However, when Holstein cows were fed Cr-picolinate,
beginning 30 d prepartum, it has been reported that liver triacylglycerol levels (d 30 o f
lactation) were lower in the Cr-fed compared with the control-fed cows (Besong et al.,
1996). In men classified as being either ketosis-prone; ketosis-resistant, nonobese; and
ketosis-resistant, obese, Rabinowitz et al. (1983) reported no change in serum
triacylglycerol concentrations following 4 mo o f Cr supplementation as CrCl3, a Brewer’s
yeast that contained Cr as GTF, or a Brewer’s yeast extract without GTF. By contrast,
Abraham et al. (1992) reported that supplemental Cr, as CrCl3, for a period o f 7 to 16 mo
lowered serum triacylglycerol concentrations. In non-insulin-dependent diabetes mellitus
patients, Lee and Reasner (1994) also reported that triacylglycerol concentrations were
significantly reduced following 2 months o f Cr supplementation as Cr picolinate.
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No interactions between fat level and age were observed for plasma insulin,
triacylglycerol, and cholesterol concentrations (P > . 10; Table 4.3). No interaction between
fat level and age was also observed for plasma glucose concentrations (P = .59; Figure 4.1);
however, when concentrations were averaged across wk, calves fed HF replacer had greater
(P = .09; Table 4.3) plasma glucose concentrations compared with calves fed BF replacer.
Figure 4.1 shows that the divergence in glucose levels between calves fed HF and LF milk
replacers did not begin to occur until 3 wk o f age. In humans fed diets considered moderate
in dietary fat (30 - 40% o f dietary energy from fat), it has been shown that insulin sensitivity
begins to decrease and hyperglycemia begins to develop at around the second to third wk
after the dietary regimen begins (Fukagawa et al., 1990; Swinbum et al., 1991). Feeding
o f a diet where 60% o f the energy is provided by fat has been shown to reduce insulin
sensitivity within days after the dietary regimen is begun (Sidery et al., 1990). In rats,
insulin sensitivity has also been shown to increase within wk after reducing dietary fat from
40 to 30% of dietary energy (Harris and Kor, 1992). In intensively-fed calves, Wijayasinghe
et al. (1984) reported that plasma glucose concentrations were greater in calves receiving
milk replacer containing higher levels o f fat. Although the difference in fat levels fed in the
Wijayasinghe study were more extreme (3 vs. 30%), they suggested that the greater dietary
availability o f glucose in the lower-fat, higher-carbohydrate-fed calves may have caused
greater release o f insulin, and this in turn resulted in maintenance o f lower steady state
plasma glucose concentrations.
To our knowledge, this is the first study to report on the effects o f Cr
supplementation in livestock fed diets with added fat. At 1 wk o f age, plasma NEFA
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concentrations were lower in calves fed HF replacer than in calves fed BF replacer,
however, from wk 2 though 5 o f age, plasma NEFA concentrations were greater in calves
fed HF replacer compared with those fed BF (fat x age; P= .0001; Figure 4.3). Jaster et al.
(1992) reported no effect o f added fat (113 and 226 g) on plasma NEFA concentrations in
calves fed only milk during the first 6 wk o f life. In humans, increases in blood lipids have
commonly been observed to be linearly correlated with dietary fat intakes (Harris and Jones,
1991).
Changes in Plasma Metabolites and Hormones in Response to a Milk Feeding Before
Calves had Access to Starter.

Changes over time and selected response variables

(prefeeding concentrations, peak concentrations, and area under the curve) for plasma
glucose, insulin, NEFA, and triacylglycerol from samples taken relative to a milk feeding,
before calves had access to starter, are presented in Figures 4.6 through 4.9, and Table 4.4,
respectively. No Cr by time effect (P = .21; Figure 4.6) was observed for plasma glucose;
however, prefeeding and peak postfeeding plasma glucose concentrations were greater ( P
< 0 1 ; Table 4.4) in the Cr-fed compared with the control-fed calves. In calves fed only
milk, Kegley et al. (1997a) also showed that C r supplementation (as CrCl3 or a Cr-nicotinic
acid complex) had no effect on pre- or postfeeding (1 h) plasma glucose concentrations
taken at various times during the first nine wk o f life.

In addition, plasma glucose

concentrations relative to a milk feeding, when calves were 9 to 10 wk old, did not differ
between Cr-fed compared with control-fed calves. In weaned lambs, Kitchalong et al.
(1995) also reported that supplemental Cr, as Cr picolinate, did not affect pre- and
postfeeding (3 h) plasma glucose concentrations at wk 2, 7, and 11 after supplementation
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Figure 4.6. Changes in plasm a glucose concentrations relative to a milk
feeding at 2 weeks o f age. Calves were fed m ilk replacer that contained
either 15% (basal) o r 22% (high) fat without (control) or with
supplemental chromium nicotinate (CrNIC). Solid line = basal fat; dash
line = high fat; square = control; circle = CrNIC.
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Figure 4.7. Changes in plasm a insulin concentrations relative to a milk
feeding at 2 weeks o f age. Calves were fed m ilk replacer that contained
either 15% (basal) o r 22% (high) fat without (control) or with
supplemental chromium nicotinate (CrNIC). Solid line = basal fat; dash
line = high fat; square = control; circle = CrNIC.
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Figure 4.8. Changes in plasm a nonesterified fatty acid (NEFA)
concentrations relative to a m ilk feeding at 2 w eeks o f age. Calves were
fed m ilk replacer that contained either 15% (basal) or 22% (high) fat
without (control) or w ith supplemental chrom ium nicotinate (CrNIC).
Solid line = basal fat; dash line = high fat; square = control; circle =
CrNIC.
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Figure 4.9. Changes in plasm a triacylglycerol concentrations relative to a
m ilk feeding at 2 weeks o f age. Calves w ere fed m ilk replacer that
contained either 15% (basal) or 22% (high) fat without (control) or with
supplemental chrom ium nicotinate (CrNIC). S olid line - basal fat; dash
line = high fat; square = control; circle = CrNIC.
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Table 4.4. Effect o f chromium nicotinate (CrNIC) and fat level on
plasma glucose, insulin, nonesterified fatty acids (NEFA) and triacylglycerol
responses relative to consumption o f milk replacer in 2 week old pre-weaned,
_________________ conventionally-fed Holstein calves1.__________________
Treatment

Fat Level
P-value2
for
Treatment

SEM

P-value2
for
Fat Level

5.5

.12

.46

7.3

6.9

.20

.11

.40

3.5

2.4

.54

.17

.15

.88

.92

1.0

.15

.72

2.4

.39

.97

2.4

2.4

.39

.99

3.0

2.7

.52

.63

2.9

2.8

.52

.86

Basal concentration,
mM

.17

.17

.02

.89

.17

.18

.01

.57

Peak concentration.
mM

.28

.28

.02

.93

.27

.29

.02

.60

Re^xnse curve
area, hmM

.20

.16

.05

.65

.17

.19

.05

.59

Basal concentration,
mM

24.4

19.3

3.4

.30

19.5

24.2

3.4

.34

Peak concentration,
mM

45.5

38.3

4.5

.27

40.7

43.1

4.5

.70

Response curve
area, hmM

28.2

38.4

9.0

.43

38.2

28.4

9.0

.45

Item
SEM

Control

CrNIC

Basal

High

17

17

16

18

5.2

5.8

.12

.004

5.4

Peak concentration,
mM4

6.7

7.5

.20

.01

Response curve
area,h-mM 5

3.3

2.6

.54

Basal concentration,
nj^ml

.98

.94

Peak concentration,
ngtal

2.4

ftapense curve
area.h-ng/ml

n
Glucose
Basal concentration,

mM3

In su lin

NEFA

Triacylglycerol

(Table con’d)
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‘There were no ( P > . 10) dietary treatment interactions, except for NEFA area under the
response curve (treatment x fat; P = .002).
Probability o f a greater F-value.
3Basal concentrations = one sample taken immediately prior to offering milk.
4Highest point following consumption o f milk.
5Response curve area = area-under the response curve relative to basal levels computed
using trapezoidal geometry for the time period 0 to 4 h after offering milk.
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was begun. Prefeeding plasma glucose concentrations did not differ (P = .46; Table 4.4)
between HF-fed and BF-fed calves and no fat by time interaction (P = .53; Figure 4.6) was
observed; however, for plasma glucose there was a tendency (P = . 11; Table 4.4) for peak
concentrations to be greater for calves fed BF replacer compared with those fed the HF
replacer. In pre-weaned dairy calves fed milk replacer containing either 5% or 25% fat, no
differences were observed in plasma glucose concentrations 1 h after the calves had
consumed their respective milk replacers (Bazin and Brisson, 1976). During the milk
feeding at 2 wk o f age, none o f the response variables (prefeeding concentration, peak
concentration height, and AUC; Table 4.4) and no dietary treatment by time effects (P >
. 10; Figure 4.7) were observed for plasma insulin concentrations. In milk only fed calves,
Kegley et al. (1997a) also showed that Cr supplementation, as CrCl3 or a Cr-nicotinic acid
complex, had no effect on prefeeding plasma insulin concentrations or changes in plasma
insulin concentrations when milk replacer was fed. Prefeeding plasma NEFA concentrations
were not different (P > .10; Table 4.4) between dietary treatments; however, a Cr by fat by
time interaction (P = .0001; Figure 4.8) was observed in response to the feeding such that,
NEFA concentrations increased in CrNIC, HF-fed calves compared with control, HF-fed
calves and decreased in CrNIC, BF-fed calves compared with control, BF-fed calves. As
observed in Table 4.4, the AUC (P = .0002) and peak concentrations (P = .17) also showed
that the level o f dietary fat influenced how plasma NEFA responded in the Cr-fed compared
with the control-fed calves. Following the milk feeding at 2 wk o f age, none of the response
variables (prefeeding concentration, peak concentration height, and AUC; Table 4.4) for
plasma triacylglycerol were affected by dietary treatments; however, in response to the milk
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feeding, plasma triacylglycerol concentrations did not increase (Cr x time; P = .02; Figure
4.9) as much in the Cr-fed as in the control-fed calves.
Changes in Plasma Metabolites and Hormones in Response to a Milk Feeding After
Calves had Access to Starter. Changes over time and selected response variables for
glucose, insulin, NEFA, and triacylglycerol from samples, taken relative to a milk feeding
after calves had access to starter for 3 wk, are presented in Figures 4.10 through 4.13, and
Table 4.5. No Cr by time effects (P > . 10; Figures 4.10, 4.11,4.12, 4.13) were observed
and Cr supplementation alone did not affect (P > .10; Table 4.5) prefeeding, peak
postfeeding, or AUC for any o f the metabolites or hormones. A fat by time interaction (P
= 68; Figure 4.10) was not observed for plasma glucose; however, prefeeding plasma
glucose concentrations tended to be greater (P = .13; Table 4.5) and peak postfeeding
plasma glucose concentrations were greater (P = .02; Table 4.5) in the HF-fed compared
to the BF-fed calves. For plasma insulin, a fat by time interaction (P = .02; Figure 4.11) was
observed such that concentrations increased more in the HF-fed calves during the initial h
after feeding compared with the BF-fed calves. When calves were fed the BF milk replacer,
prefeeding plasma insulin concentrations were higher in calves receiving supplemental Cr
compared with those fed the control; whereas, when calves were fed the HF milk replacer,
prefeeding plasma insulin concentrations were lower in calves receiving supplemental Cr
compared with those fed the control (P = . 10. Cr x fat trend; Figure 4.11). For plasma
NEFA, a Cr by fat by time interaction (P = .03; Figure 4.12) was observed such that, in the
calves fed the BF replacer, less o f a rise in plasma NEFA concentration was observed in the
Cr-fed compared with the control-fed calves; whereas, in the calves fed the HF replacer,
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Figure 4.10. Changes in plasm a glucose concentrations relative to a m ilk
feeding at 5 weeks o f age. Calves w ere fed m ilk replacer that contained
either 15% (basal) or 22% (high) fat without (control) or w ith
supplemental chromium nicotinate (CrNIC). Solid line = basal fat; dash
line = high fat; square = control; circle = CrNIC.
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Figure 4.11. Changes in plasm a insulin concentrations relative to a m ilk
feeding at 5 weeks o f age. Calves w ere fed m ilk replacer that contained
either 15% (basal) or 22% (high) fat without (control) or w ith
supplemental chromium nicotinate (CrNIC). Solid line = basal fat; dash
line = high fat; square = control; circle = CrNIC.
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Figure 4.12. Changes in plasm a nonesterified fatty acid (NEFA)
concentrations relative to a milk feeding at 5 weeks o f age. Calves were
fed m ilk replacer that contained either 15% (basal) or 22% (high) fat
without (control) or w ith supplemental chromium nicotinate (CrNIC).
Solid line = basal fat; dash line = high fat; square = control; circle =
CrNIC.
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Figure 4.13. Change in plasm a triacylglycerol concentrations relative to a
m ilk feeding at 5 weeks o f age. C alves were fed milk replacer that
contained either 15% (basal) or 22% (high) fat without (control) or w ith
supplemental chromium nicotinate (CrNIC). Solid line = basal fat; dash
line = high fat; square = control; circle = CrNIC.
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Table 4.5. Effect o f chromium nicotinate (CrNIC) and fat level on
plasma glucose, insulin, nonesterified fatty acids (NEFA) and triacylglycerol
responses relative to consumption o f milk replacer in 5 week old pre-weaned,
_________________ conventionally-fed Holstein calves1.__________________
Fat Level

Treatment

SEM

P-value3
for
Fat Level

5.2

.15

.13

6.3

6.9

.18

.02

.17

3.3

3.5

.53

.81

.20

.46

1.0

1.0

.20

.83

3.5

.55

.63

2.9

3.7

.55

.29

2.6

5.0

1.20

.28

3.1

4.4

1.16

.97

Basal concentration,
mM

.12

.15

.02

.36

.11

.16

.02

.06

Peak concentration,
mM

.23

.27

.02

.14

.21

.29

.02

.008

Response curve
area, h-mM

.20

.19

.05

.87

.16

.22

.05

.40

Basal concentration,
mM

32.7

27.9

3.2

.29

27.7

33.0

3.1

.25

Peak concentration,
mM

52.6

49.1

3.3

.46

48.1

53.7

3.3

.25

Response curve
area, h-mM

32.3

40.1

8.4

.51

36.7

35.6

8.4

.93

Item

SEM

Control

CrNIC

17

17

5.0

5.0

.15

Peak concentration,
mM4

6.5

6.6

Response curve
area, h-mM5

2.9

Basal concentration,
ng'ml

P-value2
for
Treatment

Basal

High

16

18

.79

4.8

.18

.90

4.0

.53

1.1

.92

Peak concentration,
ng/ml

3.1

Response curve
area, h-ng/ml

n
Glucose
Basal concentration,

mM3

Insulin

NEFA

Triacylglycerol

(Table con’d)
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'There were no ( P > .10) dietary treatment interactions, except for prefeeding plasma
insulin (treatment x fat; P = . 10) and peak plasma NEFA concentrations (treatment x fat;
P = .004).
Probability o f a greater F-value.
3Basal concentrations = one sample immediately prior to offering milk.
4Highest point following consumption o f milk.
5Response curve area = area-under the response curve relative to basal levels computed
using trapezoidal geometry fro the time period 0 to 4 h after offering milk.
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the rise in plasma NEFA concentration was much more dramatic in the Cr-fed compared
with the control-fed calves. Prefeeding plasma NEFA concentrations were greater (P = .06;
Table 4.5) for calves fed HF replacer compared with the calves fed the LF replacer. When
calves were fed the BF milk replacer, peak postfeeding plasma NEFA concentrations were
lower in calves receiving the Cr-supplemented replacer compared with calves receiving the
control replacer, whereas, when calves were fed the HF milk replacer, peak postfeeding
plasma NEFA concentrations were higher in calves receiving the Cr-supplemented replacer
compared with the calves receiving the control replacer (P = .004; Table 4.5). Area under
the response curve for plasma NEFA was not affected (P > . 10; Table 4.5) by treatment.
For triacylglycerol, there were no fat by time interactions (P = .96; Figure 4.13) and none
o f the response variables were affected by the fat level o f the milk replacer (P > .10; Table
4.5).
Changes in Plasma Metabolites and Hormones During an Intravenous Glucose
Tolerance Test. The changes over time and selected response variables (pre-injections
concentrations, clearance rates, and area under the curve) for glucose and insulin during the
IVGTT are presented in Figures 4.14 and 4.15 and Table 4.6, respectively. Pre-injection
plasma glucose and insulin concentrations were similar for the dietary treatments (P > . 10;
Table 4.6), and no independent dietary treatment by time interactions (P > . 10; Figures 4.14
and 4.15) were observed. The Cr by fat by time three-way interactions for glucose (P = .13)
and insulin (P = . 19) were also not significant. However, both metabolites responded in a
similar manner. When the area under the glucose response curves were calculated from 0
to 60 and from 0 to 120 min post-injection, no dietary treatment differences were observed
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Figure 4.14. Changes in plasm a glucose concentrations during an i.v.
glucose tolerance test conducted at 5 w eeks o f age. Calves w ere fed milk
replacer that contained either 15% (basal) o r 22% (high) fat without
(control) or with supplemental chrom ium nicotinate (CrNIC). Solid line
= basal fat; dash line = high fat; square = control; circle = CrNIC.
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Figure 4.15. Changes in plasma insulin concentrations during an i.v.
glucose tolerance test conducted at 5 weeks o f age. Calves w ere fed m ilk
replacer that contained either 15% (basal) or 22% (high) fat without
(control) or with supplemental chromium nicotinate (CrNIC). Solid line
= basal fat; dash line = high fat; square = control; circle = CrNIC.
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Table 4.6. Effect o f chromium nicotinate (CrNIC) and fat level on kinetic response variables1 during an i.v. glucose tolerance test in
______________________________5 week old pre-weaned, conventionally-fed Holstein calves2.______________________________
Treatment
Item

Fat Level

Control

CrNIC

17

17

4.2

4.2

1.10 ( 89, 1.24)5

1.01 (.81,1.24)

0 to 60 min

345

344

0 to 120 min

431

Basal concentrations, ng/ml
Clearance rate, %/min

P-value3for
treatment

SEM

P-value3for
treatment

.10

.37

Basal

High

16

18

.73

4.1

4.2

.57

1.15 ( 93, 1.40)

.97 (.77,1.18)

10.4

.93

345

344

10.5

.94

426

26.2

.90

424

433

26.0

.80

.79

.81

.09

.84

.83

.76

.08

.57

.95

1.20

.55

.74

1.20

.95

.55

.75

0 to 60 min6

91(68,124)

78(58,106)

.45

74(34,101)

97 (72,130)

.20

0 to 120 min6

140(108,182)

112(87, 146)

.22

106(81, 138)

149(116, 192)

.07

2.45 (1.59,3.30)

3.76(2.63, 309)

.09

4.08(2.87, 3.30)

2.21 (1.14,3.18)

n

SEM

Glucose Kinetics
Basal concentrations, mM
Clearance rate, %/min4

.10

.24

Response curve area, min-mM
Post-challenge interval

Insulin Kinetics

Response curve area, min'ng/ml
Post-challenge interval

Insulin Sensitivity Index7

.02
(Table con’dj
o
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‘Kinetic criteria: basal concentrations immediately prior to challenges; clearance rate computed from 20 to SO min after glucose challenge.
2There were no (P > . 10) dietary treatment interactions.
Probability o f a greater F-value.
4For statistical analysis, glucose clearance rates were transformed by raising the original values to the .5 power.
*For glucose clearance rate, insulin response curve area, and insulin sensitivity index, all means are based on analysis o f transformed data;
consequently, the lower and upper 95% confidence limits for each mean are given in parentheses.
6For statistical analysis, insulin response curve areas were transformed by taking the natural log o f the original values.
7Based on a computer model (Bergman, 1997): larger number indicates = more insulin sensitive: Insulin sensitivity indexes were transformed
by raising the original values to the .5 power.
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(P > . 10; Table 4.6). During the initial h post-injection (0 to 60 min), insulin AUC was also
not affected (P > . 10) by dietary treatments; however, over the 2-h sampling period (0 to
120 min), area under the insulin response curve was greater (P = .07) in calves fed the HF
replacer compared with those fed the BF replacer. Similar responses have been observed in
milk-fed calves (Kegley et al., 1997a) and in ruminating lambs (Fomea et al., 1994;
Kitchalong et al., 1995; Forbes et al., 1998) and calves (Bunting et al., 1994).
Glucose and (or) insulin clearance rates following an IVGTT or an IV1CT have been
the primary diagnostic tool used to evaluate whether supplemental Cr affected glucose
tolerance/insulin sensitivity. In the current experiment, glucose and insulin clearance rates
were not affected (P > . 10; Table 4.6) by the dietary treatments. Kegley et al. (1997a) also
reported that supplemental Cr had no effect on glucose clearance rate following an IVGTT
conducted in 9 to 10-wk old intensively-fed calves. Fomea et al. (1994), Kitchalong et al.
(1995), and Forbes et al. (1998) have also reported no effect o f supplemental Cr-picolinate
on glucose clearance rates in lambs administered an IVGTT. Bunting et al. (1994) reported
supplemental Cr (as Cr-picolinate) increased glucose clearance rates by 40% in steers and
by 27% in heifer calves during an IVGTT. It is noteworthy that the clearance rates were
faster for the older, milk-fed calves (fed a 20% fat milk replacer was fed) used by Kegley
et al. (1997a) compared to the younger, conventionally-fed calves (fed on average a 19%
fat milk replacer) used in the current experiment (average o f all treatments = 1.59 vs 1.06
%/min, respectively).
As mentioned in the material and methods, the plasma glucose and insulin
concentrations obtained from the IVGTT were also evaluated by a computer modeling
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procedure that allowed us to obtain an index o f insulin-dependent glucose clearance (insulin
sensitivity index). A higher index value indicates that the subject is more insulin sensitive.
The insulin sensitivity index values obtained were similar to those that have been reported
for non-insulin dependent diabetic human subjects (Watanabe et al., 1995) and for humans
fed a low fat compared to a high fat diet (Lovejoy, unpublished). More classical methods,
such as the pancreatic suppression test and glucose clamps, have been compared to the
minimal model approach. All methods used have shown that insulin sensitivity decreases
as the level o f dietary fat in the diet increases (Sidery et al., 1990; Harris and Kor, 1992).
For the current experiment, both Cr level and dietary fat level had independent effects on
the insulin sensitivity index. Calves fed the Cr-supplemented replacer had higher (P = .09)
index values than calves fed the control replacer (3.76 vs 2.45, respectively) and calves fed
the BF replacer had higher (P = .02) index values than calves fed the HF replacer (4.08 vs.
2.21, respectively). The fat effect supports our original hypothesis that feeding calves a
higher level o f dietary fat would have reduced insulin sensitivity. This Cr effect is similar
to that o f Kegley et al. (1997a) where they suggested that Cr supplementation may prolong
insulin sensitivity prior to the time calves are weaned.
Changes in Plasma Metabolites and Hormones During an Epinephrine Challenge.
Changes plasma concentrations over time and selected response variables (pre-injection
concentrations and area under the curve) for glucose, NEFA, and triacylglycerol during the
epinephrine challenge are represented in Figures 4.16 through 4.18, and Table 4.7. Pre
injection plasma glucose, NEFA, and triacylglycerol concentrations did not differ between
treatments (P > . 10; Table 4.7); however, there was a tendency for plasma triacylglycerol
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concentrations to be greater (P = .11; Table 4.7) in calves fed the HF-replacer compared
with calves fed the LF-replacer. Plasma glucose, NEFA, and triacylglycerol concentrations
all peaked within 10 min after the epinephrine was given (P = 0001). Plasma glucose and
NEFA concentrations returned to pre-injection levels by around 60 min and remained stable
over the ensuing h. For all dietary treatments, a similar pattern was observed for plasma
triacylglycerol concentrations throughout the first 40 min post-injection; however, after
plasma triacylglycerol concentrations reached their lowest post-injection

point,

concentrations began to increase in the control-fed calves but remained relative stable in the
Cr-fed calves. The triacylglycerol area under the curve from 0 to 60 min did not differ (P
= .22) between Cr-fed and control-fed calves; but, over the entire 120 min sampling period,
there was a slight tendency (P = .15) for area under the curve to be lower in Cr-fed
compared with the control-fed calves (234 vs 506, respectively). Because epinephrine is a
potent catecholamine (Brockman and Laarveld, 1986) and catecholamines have been shown
to stimulate glycogenolysis, gluconeogenesis, and lipolysis in ruminants and nonruminants
(Blum et al., 1982; Mersmann, 1989; Chapa et al., 1996), the rise in glucose, NEFA, and
triacylglycerol was expected. Based on the current findings, it is possible that Cr helps to
stabilize plasma lipid concentrations.
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Figure 4.16. Changes in plasma glucose concentrations relative to an
epinephrine infusion at 5 weeks o f age. Calves were fed milk replacer that
contained either 15% (basal) or 22% (high) fat without (control) or w ith
supplem ental chromium nicotinate (CrNIC). Solid line = basal fat; dash
line = high fat; square = control; circle = CrNIC.

1.5

<

1"

0.5
0

10 20

40
60
Time, min

80

100

120

Figure 4.17. Changes in plasm a nonesterified fat acid (NEFA)
concentrations relative to an epinephrine infusion at 5 weeks o f age.
Calves w ere fed m ilk replacer that contained either 15% (basal) o r 22%
(high) fat without (control) or with supplemental chromium nicotinate
(CrNIC). Solid line = basal fat; dash line = high fat; square =control;
circle = CrNIC.
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Figure 4.18. Changes in plasm a triacylglycerol concentrations relative to
an epinephrine infusion at 5 weeks o f age. Calves w ere fed m ilk replacer
that contained either 15% (basal) o r 22% (high) fat without (control) or
w ith supplemental chromium nicotinate (CrNIC). Solid line = basal fat;
dash line = high fat; square = control; circle = CrNIC.
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Table 4.7. Effect of chromium nicotinate (CrNIC) and fat level on kinetic response variables' during an i.v. epinephrine infusion in 5
Treatment
Item

Fat Level
P-value3for
treatment

SEM

P-value3for
Fat Level

.13

.40

Basal

High

16

18

.66

3.46

3.62

.16
.43

15.3(8.4,24.2)
27.7(9.9,50.7)

26.9(18.0,37.7)
46.3(25.4,72.1)

.06

.61

.79

.82

.06

.81

9.3 ( 4 .2 , 15.4 )
17.0

5.5

.69
.96

10.0(4.7,16 .5 )
19.5

7.1 (2.6,12.6)
14.0

5.5

.44
.48

19.0

18.7

2.0

.91

16.5

21.2

2.0

.11

256
506

163
234

53.2
129.9

.22

217
390

303
349

53.3
128.8

.82

Control

CrNIC

17

17

3.49

3.58

2 5 . 3 ( 16. 5, 36.2 )’
4 2 . 8 ( 22. 1, 68 .7 )

16.6(9.5, 25.4)
30.7(12.7,53.7)

.78

.83

7.7 ( 3 .0 . 13.6 )
16.6

Basal concentration, mg/dl
Response Curve area, mM-min
Post-challenge interval
0 to 60 min
0 to 120 min

SEM

Glucose Kinetics
Basal concentration, mM
Response Curve area, min-mM
Post-challenge interval
0 to 60 min4
0 to 120 min4

.13

.07
.23

NEFA Kinetics
Basal concentration, mM
Response Curve area, mM-min
Post-challenge interval
0 to 60 min4
0 to 120 min
Triacylglycerol Kinetics

.15

.86

(Table con’d)
vO
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'Kinetic criteria: basal concentrations are average of 2 samples taken 10 min and immediately prior to challenge.
2There were no (P > . 10) dietary treatment interactions.
Probability of a greater F-value.
4For statistical analysis, glucose (0 to 60 and 0 to 120 min) and insulin (0 to 60 min) response curve areas were transformed by raising the
original values to the .4 power.
*For glucose (0 to 60 and 0 to 120 min) and insulin (0 to 60 min) response curve areas, all means are based on analysis of transformed data;
consequently, the lower and upper 9S% confidence limits for each mean are given in parentheses.
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CHAPTER V
OVERALL SUMMARY AND CONCLUSIONS
Two experiments were conducted to determine the effects o f supplemental
chromium (Cr; 1 ppm), as chromium picolinate (CrP; exp. 1) or chromium nicotinate
(CrNIC; exp. 2), on performance, glucose metabolism, and lipid metabolism o f
conventionally-fed Holstein calves.
Supplemental CrP (Exp. 1; between birth and 2 to 3 wk post-weaning) was observed
to increase ADG in bull calves but to decrease ADG in heifer calves. Additionally, modest
increases in ADG (Exp. 2) were observed while calves were fed milk alone. From these
experiments, it was concluded that performance benefits alone will not justify usage o f
supplemental Cr in conventionally-reared dairy calves.
In cattle, research efforts have identified two situations in which Cr supplementation
might have a commercial application: newly arrived feedlot cattle and first-lactation dairy
cattle during the transition period. In swine, research has determined, that under some
situations, Cr supplementation might favorably alter metabolism with resultant
improvements in performance. Overall, it appears that supplemental Cr tends to improve
performance in situations in which demands (nutritional, metabolic, environmental, etc.)
placed on the animal are high. It is possible that the effects o f Cr on performance were
minimal in our experiments, because the demands imposed on the calves were reduced
through optimum calf management and husbandry practices. For instance, in the current
experiments, care was taken to ensure that adequate amounts o f high quality colostrum was
provided to all calves in a timely manner. Additionally, only calves readily drinking from
99
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buckets and not displaying any apparent health problems were included in the current
experiment. These are probably the primary reasons that the incidence and severity o f calf
scours were low and that the rates o f gain tended to exceed those reported for calves of
similar ages, and when similar feeding regimes were employed. Heinrichs et al. (1994)
reported that 25.6% and 75.5% o f calves on US farms receive less than 1.9 L and less than
3.8 L o f colostrum within the first 24 h o f life, respectively. Even when an acceptable
quality o f colostrum (> 50 mg o f immunoglobulins/mL o f colostrum; Scott and Fellah,
1983) is used it has been determined that calves receiving less than 1.9 L of this colostrum
will not receive an adequate level o f immunoglobulins (Scott et al., 1981). Calves receiving
between 1.9 and 3.8 L also may not receive adequate immunoglobulins (Heinrichs et al.,
1994). Whether Cr supplementation would have greater effects on performance (gain,
health) in dairy calves, raised under less than ideal calf management practices, warrants
investigation.
From Exp. 1 and 2, it was concluded that supplemental Cr had limited and (or)
inconsistent effects on the metabolites and hormones measured before (prefeeding) and after
milk feedings. Supplemental CrP did not affect prefeeding plasma glucose, insulin, cortisol,
or IGF-1 concentrations and did not affect the postfeeding rise in plasma glucose or insulin
concentrations. Supplemental CrNIC did not affect prefeeding plasma glucose, insulin,
triacylglycerol, or cholesterol concentrations, although there was a tendency for CrNIC to
lower prefeeding plasma insulin concentrations. Regarding NEFA, supplemental CrP
lowered pre- and postfeeding plasma NEFA concentrations in Exp. 1, whereas in Exp. 2,
prefeeding plasma NEFA concentrations w o e greater when CrNIC was supplemented. This
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latter effect was largely because plasma NEFA concentrations in the calves fed the CrNIC,
high fat-replacer did not decrease with age to the extent observed for the other treatment
groups. From Exp. 2, basal cholesterol and triacylglycerol (under some situations) also
tended to show that fat level o f the diet affected how these metabolites responded to
supplemental Cr. In response to milk feedings (Exp. 2 only), CrNIC and fat level had only
small effects on the blood metabolites measured; however, the findings did suggest that fat
level o f the diet needs to be considered when evaluating blood metabolite responses to
supplemental Cr.
From Exp. 1, it was concluded that supplemental CrP did not affect
gluconeogenesis. From Exp. 1 and 2, it was concluded that supplemental Cr did not affect
glucose and insulin changes ova- time or glucose clearance rates in response to an IVGTT.
However, interpretation o f the IVGTT data by the minimal model program (Exp. 2 only),
showed that calves fed CrNIC were more insulin sensitive than control-fed calves and that
BF-fed calves were less insulin sensitive that HF-fed calves. Further research needs to be
conducted to determine if use o f the minimal model approach would provide a better
evaluation o f changes in insulin sensitivity in the neonatal calf.
Many unknown factors remain in Cr research. The need for Cr supplementation of
practical livestock diets appears to depend on the C r status o f the animal, the amount of
bioavailable Cr in feedstuff's, and the exposure o f the animals to situations under which
greater demands are placed on the animal. To date, few studies, especially in ruminants,
have been conducted to compare different Cr sources and (or) levels supplemented.
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